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Novel negative regulation of LIN-12/Notch in Caenorhabditis elegans   
Yuting Deng 
Proper cell fate specification is crucial for development, and dysregulation in 
cellular signaling pathways can lead to deleterious effects like cancer. The conserved LIN-
12/Notch signaling pathway mediates fate specification in many cellular contexts, and 
multiple regulatory mechanisms ensures appropriate LIN-12/Notch activity in each 
context. Here, I have identified several cis-regulatory domains and trans-acting factors that 
contribute to the negative regulation of LIN-12/Notch in Caenorhabditis elegans.  
In this thesis, I find that LIN-12/Notch requires binding to LAG-1/CSL and 
association with the nuclear complex for protein turnover in the C. elegans vulval precursor 
cells (VPCs). I also identify two layers of negative regulation in the VPCs and their 
descendants. The E3 ubiquitin ligase SEL-10/Fbw7 mediates degradation of LIN-12/Notch 
via the PEST domain in the VPCs, while a novel structural conformation in the C-terminal 
end of the LIN-12/Notch intracellular domain is required for downregulation in the 
descendants.  
Through an RNAi screen for negative regulators, I isolated 13 conserved kinases 
that downregulate LIN-12/Notch activity. Of these 13 kinases, CDK-8 had been previously 
implicated in Notch turnover, while the other 12 are novel negative regulators. I provide 
evidence that 5 of the kinases regulate LIN-12/Notch through modulation of the 
intracellular domain. Furthermore, I conduct a deeper investigation into CDK-8, which is 
the kinase component of the Mediator complex. I determine that CDK-8 acts with the rest 
 
 
of the Cdk8 Kinase Module and independent of the Mediator core to negatively regulate 
LIN-12/Notch, and that CDK-8 kinase activity is required for this process. Lastly, I find 
that sur-2/MED23 and lin-25/MED24 are required for LIN-12/Notch ligand transcription, 
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Chapter 1. General Introduction  
 
2 
1. Regulation of LIN-12/Notch  
Proper cell fate specification is an essential part of development in nature, and 
dysregulation in the cellular signaling pathways can lead to deleterious effects like cancer. 
The complexities of the Notch signaling pathway enables careful regulation of the 
multitude of cellular processes that Notch is involved in.  
Notch is a single pass transmembrane protein, and both the structure of the Notch 
receptor and its signaling pathway are well conserved. There are two C. elegans Notch 
orthologues, LIN-12 and GLP-1, one D. melanogaster Notch, and four Notch orthologues 
in H. sapiens, Notch(1-4) (Figure 1). All the orthologs of Notch present extracellular 
domains that contain a variable number of EGF repeats, ranging from 13 in C. elegans 
GLP-1 to 36 in H. sapiens NOTCH1. This is followed by three LNR (Lin-12/Notch 
Repeats) domains that mediate negative regulation of Notch, and the heterodimerization 
domain, consisting of HD-N and HD-C domains. The intracellular domain contains a RBP-
JK associated molecule (RAM) domain followed by six ankyrin repeats (ANK), a 
transactivation domain (TAD) and a PEST domain, which will be discussed in greater 
detail below.  
 
1.1 The Notch signaling pathway  
In canonical Notch signaling, both the Notch receptor and its DSL 
(Delta/Serrate/Lag) type ligands are transmembrane proteins with large extracellular 
domains that consist of EGF repeats (Tax & Thomas, 1994; Tax, Thomas, Ferguson, & 
 
3 
Horvitz, 1997). The Notch receptor is cleaved at site 1 (S1) by furin during maturation 
(Logeat et al., 1998), but ligand binding initiates a two-step proteolytic cleavage of the 
Notch receptor (Figure 2). ADAM (a disintegrin and metalloprotease) family 
metalloproteases, including SUP-17/Kuzbanian and ADM-4/TACE, catalyze the first 
cleavage event at site 2 (S2) (Brou et al., 2000; Jarriault & Greenwald, 2005; Wen, 
Metzstein, & Greenwald, 1997). The S2 site is normally concealed within the Notch 
Negative Regulatory Region (NRR), which includes the LNRs (Sanchez-Irizarry et al. 
2004; Gordon et al. 2009). Binding of the DSL ligands to Notch unfolds the NRR to expose 
the S2 cleavage site to proteolytic cleavage by the ADAM proteases. g-secretase, an 
enzyme complex that contains SEL-12/presenilin, HOP-1/presenilin, APH-2/nicastrin, 
PEN-2 and APH-1, mediates the second cleavage at site 3 (S3)  (Levitan & Greenwald, 
1995; X. Li & Greenwald, 1997; Struhl & Greenwald, 1999, 2001). This releases the Notch 
intracellular domain (NICD), which translocates to the nucleus and interacts with LAG-
1/CSL (CBF1/Suppressor of Hairless/LAG-1) and SEL-8/Mastermind-like (MAML) to 
form a nuclear complex and activate the transcription of target genes (Christensen, 
Kodoyianni, Bosenberg, Friedman, & Kimble, 1996; Doyle, Wen, & Greenwald, 2000; 
Petcherski & Kimble, 2000; Struhl, Fitzgerald, & Greenwald, 1993; L. Wu et al., 2000). 
 
1.2 Known negative regulation of LIN-12/Notch 
 Notch receptors and DSL ligands are produced in the endoplasmic reticulum (ER), 
then trafficked through the Golgi apparatus to reach the plasma membrane. There are 
checkpoints in this process that negatively regulate the Notch protein. The unfolded protein 
response (UPR) prevents aberrant activity from misfolded proteins, and sel-1 plays and 
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important role in the ER-associated protein degradation of Notch (Grant & Greenwald, 
1996, 1997; Urano et al., 2002). sel-9 encodes a p24 protein implicated in the quality 
control mechanism during transportation of Notch from the ER to the Golgi apparatus 
(Wen & Greenwald, 1999). Loss of these important negative regulators result in a buildup 
of aberrant Notch protein and elevated activity.  
Endocytosis and trafficking are required for ligand-dependent Notch activation, 
however, they are also important for the negative regulation of Notch signaling. Inactive 
Notch receptors that do not bind to DSL ligands are constitutively endocytosed and 
recycled to the cell membrane (McGill, Dho, Weinmaster, & McGlade, 2009), or degraded 
in the lysosome (Jehn, Dittert, Beyer, von der Mark, & Bielke, 2002). Numb is an endocytic 
adapter protein that recruits the E3 ubiquitin ligase WWP-1/Itch/NEDD4/Su(Dx) to 
promote degradation of the Notch receptor (Beres et al., 2011; Shaye & Greenwald, 2005) 
and to regulate post-endocytic sorting events for Notch (McGill et al., 2009). In return, 
Notch can downregulate Numb protein levels, resulting in a positive-feedback loop for 
Notch activity (Chapman, Liu, Sahlgren, Dahlqvist, & Lendahl, 2006). ESCRT complexes 
and lethal giant discs (lgd) are involved in the sorting of Notch from early endosomes into 
multivesicular bodies (MBVs), and they are also required for Notch degradation, as 
disruption of this process leads to ligand-independent activation of Notch (Childress, Acar, 
Tao, & Halder, 2006; Jaekel & Klein, 2006; Vaccari, Lu, Kanwar, Fortini, & Bilder, 2008). 
Proteins in the HOPS and AP-3 complexes assist in trafficking Notch from late endosomes 
to lysosomes and are required for Notch degradation (Wilkin et al., 2008). SEL-
2/neurobeachin/LRBA plays a role in the endocytosis of LIN-12 from the basolateral 
surface of polarized epithelial cells to prevent aberrant basolateral protein accumulation 
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and subsequent elevated Notch activity (de Souza, Vallier, Fares, & Greenwald, 2007). 
These proteins involved in endocytosis and trafficking are important for proper activation 
and regulation of the Notch signaling pathway.   
Another important negative regulator of Notch is the E3 ubiquitin ligase, SEL-
10/Fbw7 (Gupta-Rossi et al., 2001; Hubbard, Wu, Kitajewski, & Greenwald, 1997; Oberg 
et al., 2001; Sundaram & Greenwald, 1993b; G. Wu et al., 2001). SEL-10 is a Cdc4-related 
protein containing an F-box and seven WD-40 repeats. SEL-10/Fbw7 binds to the Cdc4 
phospho-degron (CPD) in the PEST region of the Notch intracellular domain (Figure 3), 
and uses its F-box to recruit the rest of the SCF complex, consisting of SKP1 (S-phase 
kinase-associated protein 1), CUL1 (cullin1), and RBX1 (RING box 1) (Welcker & 
Clurman, 2008). This complex subsequently ubiquitinates Notch to target it for 
degradation. The importance of SEL-10/Fbw7 in the Notch signaling pathway is discussed 
below.  
 
1.3 Regulatory sequences in the LIN-12/Notch intracellular domain 
While many aspects of the Notch receptor sequence are required for the different 
steps in the Notch signaling pathway, the Notch intracellular domain constitutes the 
segment required for target activation and contains many regulatory domains. Many studies 
involving cis-regulatory modification and trans-acting factors have identified 
phosphorylation, ubiquitylation, and acetylation sites on LIN-12/Notch intracellular 
domain that are important for its negative regulation. The canonical NICD consists of a 
Rbp-associated molecule (RAM) domain that mediates interactions with CSL; an ankyrin 
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(ANK) repeat domain; and a C-terminal PEST [rich in proline (P), glutamic acid (E), serine 
(S) and threonine (T)] degradation domain (Kovall & Blacklow, 2010). Human Notch also 
contains a transactivation domain (TAD), which recruits histone acetyltransferases 
(Kurooka & Honjo, 2000); the TAD is not conserved in C. elegans lin-12, but LIN-
12(intra) beyond the ANK repeats behaves as a transcriptional activator in yeast (Hubbard, 
Dong, & Greenwald, 1996) 
A downregulation targeting sequence (DTS) in the RAM domain of LIN-12/Notch 
is required for degradation via interaction with WWP-1/Itch/NEDD4/Su(Dx) and multi-
vesicular endosome (MVE) sorting (Shaye & Greenwald, 2002, 2005). The DTS contains 
a di-leucine motif and serine/threonine residues that are required for internalization of LIN-
12, and lysine residues near the DTS are required for degradation (Shaye & Greenwald, 
2005).  In contrast, Drosophila Notch does not have a DTS, but has a C-terminal PPXY 
signal that promotes association with dNedd4 and internalization of the protein (Sakata et 
al., 2004). The PPXY signal is not conserved in C. elegans or vertebrate Notch, but the 
requirement for WWP-1/Itch/NEDD4/Su(Dx) remains consistent, pointing towards 
different regulatory regions and mechanisms for targeting Notch for internalization.  
In the LIN-12/Notch intracellular domain, the PEST sequence contains a conserved 
Cdc4 phospho-degron (CPD) motif containing a central threonine and +4 serine that are 
targeted for phosphorylation. The phosphorylated CPD recruits the E3 ligase SEL-
10/Fbw7 to induce ubiquitin-mediated degradation of the intracellular domain (Welcker & 
Clurman, 2008). The PEST domain also contains a S4 sequence that enables regulatory 
serine phosphorylation events. Mutation of the S4 region has been shown to stabilize the 
intracellular domain and the nuclear complex (Chiang et al., 2006). Furthermore, 
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acetylation and deacetylation by Sirt1 of NICD has been linked to regulating Notch half-
life, as acetylation of NICD may be interfering with its ubiquitin-mediated degradation 
(Guarani et al., 2011). The multiple mechanisms of downregulating Notch demonstrate the 
importance of negative regulators in the signaling pathway and the consequences of 
disrupting their functions. 
 
1.4 The significance of Notch in cancer 
Notch can serve as an oncogene as well as a tumor suppressor, where dysregulation 
of signaling as an oncogene has been associated with the development of several cancers, 
especially T-cell acute lymphoblastic leukemia (T-ALL) (Roy, Pear, & Aster, 2007). High 
levels of NOTCH1 signaling is found in 60% of T-ALL patients (Weng et al., 2004). The 
main causes of high Notch activity involve activating mutations and impaired degradation 
of Notch, and these factors have been found alone or in combination in T-ALL patients. 
(Weng et al., 2004). Mutations in the LNR and HD region can induce spontaneous, ligand-
independent activation of Notch (I. Greenwald & Seydoux, 1990; Malecki et al., 2006). 
Meanwhile, mutations in the PEST sequence resulting from frame-shift or nonsense 
substitutions prevents degradation of the Notch intracellular domain (de la Cova & 
Greenwald, 2012; Ferrando, 2009; Mango, Maine, & Kimble, 1991). SEL-10/Fbw7 also 
appears to function as a tumor suppressor in T-ALL, where loss-of-function mutations in 
FBXW7 can similarly prevent ubiquitin-mediated turnover of Notch (Welcker & Clurman, 
2008). 15% of all T-ALL cases contain mutations or deletions in FBXW7, and they do not 
occur concurrently with mutations in the PEST domain, indicating the important role 
FBXW7 plays in the degradation of Notch (O'Neil et al., 2007). These findings highlight 
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the significance of studying negative regulation of LIN-12/Notch to provide more insight 
into where dysregulation of Notch can occur. 
 
2. Signaling events during VPC fate specification  
The Caenorhabditis elegans hermaphrodite vulva is a valuable paradigm for 
investigating highly conserved signaling pathways. The VPC developmental process is 
both spatially and temporally precise, following a characteristic lineage. Genetic analyses 
and molecular characterization have identified the genes involved in specification of the 
stereotypical VPC cell fate pattern. Initially, there are six equipotent VPCs, numbered P3.p 
through P8.p consecutively (Figure 4). The 1° fate is specified in P6.p by an inductive 
signal from the anchor cell (AC) of the gonad and mediated by a EGFR-Ras-MAPK 
pathway. The 2° fate is specified in P5.p and P7.p by a lateral signal produced by the 1° 
cell that activates LIN-12/Notch signaling (Sternberg, 2005). The descendants of P5.p, 
P6.p, and P7.p, which adopt the 2°-l°-2° fate, respectively, divide and undergo 
morphogenesis to form the adult vulva (Sharma-Kishore, White, Southgate, & 
Podbilewicz, 1999; Sulston & Horvitz, 1977). P3.p, P4.p and P8.p do not receive either the 
inductive signal or the lateral signal, and adopt the default 3° fate, dividing once and fusing 
to the major hypodermal syncytium (Sulston & White, 1980). Modification of this complex 
VPC signaling pathways can disrupt the stereotypical 3°-3°-2°-1°-2°-3° pattern and cause 
a visible mutant phenotype.  
 
2.1. The EGFR-Ras-MAPK inductive signaling pathway  
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Vulva development is induced when the anchor cell (AC), a specialized cell in the 
somatic gonad overlying the VPCs, produces an inductive signal (Kimble, 1981). The AC 
is necessary and sufficient to induce vulval development through the inductive signal, the 
EGF-like ligand, LIN-3 (Hill & Sternberg, 1992).  Overexpression of LIN-3 is sufficient 
to induce ectopic 1° vulval fates in the VPCs that normally express the 3° fate, resulting in 
a Multivulva phenotype (Hill & Sternberg, 1992; Katz, Hill, Clandinin, & Sternberg, 
1995). Functionally redundant SynMuv (Synthetic Multivulva) genes, like lin-15AB, 
repress lin-3 expression in hyp7, and loss of SynMuv genes can also cause the Multivulva 
phenotype (Cui et al., 2006; Myers & Greenwald, 2005).  
LIN-3 activates LET-23/EGFR, which encodes a receptor tyrosine kinase (RTK) 
of the EGF receptor (EGFR) subfamily (Aroian, Koga, Mendel, Ohshima, & Sternberg, 
1990). SEM-5/GRB2 docks onto the activated LET-23/EGFR (Clark, Stern, & Horvitz, 
1992), which subsequently recruits LET-341/SOS-1 to activate LET-60/Ras (Han & 
Sternberg, 1990). Activation of LET-60/Ras leads to the occurrence of downstream Ras-
MAPK signaling events, which involve the proteins LIN-45/Raf (Han, Golden, Han, & 
Sternberg, 1993), MEK-2/MEK, and MPK-1/ERK (Lackner, Kornfeld, Miller, Horvitz, & 
Kim, 1994).  
Two direct targets of the MAPK pathway are the transcription factors LIN-1, an 
Ets domain transcription factor (Beitel, Tuck, Greenwald, & Horvitz, 1995; Jacobs, Beitel, 
Clark, Horvitz, & Kornfeld, 1998), and LIN-31, a winged-helix transcription factor 
homologous to HNF-3/forkhead (Miller, Gallegos, Morisseau, & Kim, 1993; Tan, Lackner, 
& Kim, 1998). LIN-1 plays a critical role in establishing vulval cell fates, as it is both 
required for inhibition and activation of 1° cell fate (Beitel et al., 1995). LIN-1 is 
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sumoylated to repress transcription of target genes that promote the 1° fate. After the 
MAPK pathway is activated in P6.p, MPK-1/ERK phosphorylates LIN-1 to disrupt the 
sumoylation, relieving the LIN-1-mediated transcriptional repression and allowing genes 
that promote the 1° fate to be transcribed in P6.p (Leight, Glossip, & Kornfeld, 2005). LIN-
31 forms a complex with LIN-1, and is required to promote and repress induced vulval 
fates (Miller et al., 1993; Tan et al., 1998). Since lin-31 is also transcribed in all the VPCs 
and their descendants, the lin-31 promoter is commonly used as a promoter for driving 
VPC-specific transgenes.  
 
2.2. The LIN-12/Notch lateral signaling pathway 
After P6.p assumes the 1° cell fate, it expresses the lateral signal encoded by the 
DSL ligands for LIN-12/Notch. Ten DSL ligands were computationally identified, and at 
least three DSL ligands, lag-2, apx-1, and dsl-1, are components of the lateral signal (Chen 
& Greenwald, 2004). The ligands activate the LIN-12/Notch reception in the neighboring 
P5.p and P7.p cells, and these cells adopt the 2° cell fate (I. S. Greenwald, Sternberg, & 
Horvitz, 1983). Although there exist two biochemically interchangeable C. elegans Notch 
proteins, LIN-12 and GLP-1, they mostly mediate distinct cell fate decisions, and GLP-1 
does not affect vulval development (I. Greenwald, 2005).  
Several LIN-12 targets play a role in vulval development. lst-5 is a direct 
transcriptional target that encodes a C2H2 zinc finger protein (Choi et al., 2009). Another 
LIN-12 transcriptional target is lin-11, which encodes a LIM domain transcription factor 
(Freyd, Kim, & Horvitz, 1990). mir-61 is another direct transcriptional target that promotes 
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lateral signaling; it encodes a microRNA that downregulates VAV-1, a guanine nucleotide 
exchange factor for Rho/Rac family GTPases and negative regulator of lin-12 activity (A. 
S. Yoo & Greenwald, 2005). dpy-23, lst-1, lst-2, lst-3, and lst-4 have also been 
computationally identified and experimentally verified to be targets of LIN-12/Notch 
(Andrew S Yoo, Bais, & Greenwald, 2004).  
 
2.3. Interplay of the EGFR and LIN-12/Notch signaling pathways in VPCs 
Complex regulatory mechanisms control the inductive and lateral signaling 
pathways to ensure precise and robust VPC fate patterning. Activation of the EGFR-Ras-
MAPK pathway in P6.p induces expression of eps-8, which forms a positive feedback loop 
by maintaining high levels of LET-23/EGFR at the basolateral membrane (Stetak et al., 
2006). This reinforces LET-23/EGFR activity in P6.p. Also, activation of the EGFR-Ras-
MAPK pathway in P6.p induces endocytosis-mediated downregulation of LIN-12, which 
is required for DSL ligands to successfully activate LIN-12 in adjacent VPCs (Shaye & 
Greenwald, 2002, 2005).  
In P5.p and P7.p, a low level of EGFR-Ras-MAPK activity is initially activated by 
the low, graded amounts of the inductive signal, LIN-3, from the AC. However, activation 
of the LIN-12/Notch signaling in the presumptive 2° cells induces the expression of several 
negative regulators of EGFR-Ras-MAPK activity, such as ark-1, lip-1, lst-1, lst-2, lst-3, 
lst-4, and dpy-23 (Berset, Hoier, Battu, Canevascini, & Hajnal, 2001; Hopper, Lee, & 
Sternberg, 2000; Andrew S Yoo et al., 2004) This antagonizes the inductive signaling in 
P5.p and P7.p to ensure that EGFR-Ras-MAPK activity is shut down in those cells. Another 
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LIN-12 target, mir-61, downregulates a negative regulator of lin-12 activity, vav-1, 
resulting in a net positive feedback loop for LIN-12 signaling (A. S. Yoo & Greenwald, 
2005)  
 
2.4. VPCs as a model for studying signaling pathways  
Mutations in the precise signaling pathways in VPC specification can cause defects 
that are visible in the dissecting microscope. A Vulvaless phenotype is caused by mutations 
that lead VPCs that normally express the 1° or 2° fate to adopt the 3° fate, such as a decrease 
in the activity of the EGFR-Ras-MAPK pathway. Mutations that cause constitutive MAPK 
or Notch activity can induce VPCs that normally express the 3° fate to adopt the 1° or 2° 
fate, resulting in a Multivulva phenotype (Sternberg, 2005). The ability to screen for 
quantifiable mutant phenotypes in the VPCs has resulted in the elucidation of many 
components of the EGFR-Ras-MAPK and Notch pathways (Eisenmann & Kim, 2000; 
Ferguson & Horvitz, 1985; Seydoux, Savage, & Greenwald, 1993). Suppressor screens 
have also proven useful for identifying new genes and alleles. For example, a screen for 
reversions of the Multivulva phenotype identified sel-12, an important component of the 
g-secretase complex (Levitan & Greenwald, 1995). The combination of our deep 
knowledge of the VPC signaling pathways and our tools to manipulate cell fate allows us 





3. Mediator is a complicated multiprotein complex 
Mediator, a large multiprotein complex consisting of about 26 subunits in 
mammals, links DNA-bound transcription factors to the basal transcription machinery 
(Taatjes, 2009). Most of the subunits are conserved between yeast and humans, and there 
are additional, metazoan-specific subunits as well.  Based on structural and biochemical 
information, subunits have been assigned to Head, Middle or Tail modules of the "core" 
Mediator complex (Imasaki et al., 2011; Lariviere et al., 2013; Tsai et al., 2014; Vojnic et 
al., 2011), with the most recent assignments based on cryo-EM analysis of yeast and human 
complexes.   
Mediator acts as a bridge between transcription factors and RNA polymerase II (Pol 
II), recruiting Pol II to activating domains of proteins to form a pre-elongation complex 
(PEC). MED26 is a regulatory module that reversibly associates the Mediator core and 
recruits the Super Elongation Complex (SEC) to promote activation of target genes 
(Takahashi et al., 2011; Takahashi et al., 2015). The Cdk8 Kinase Module also associates 
reversibly with the Mediator core in a mutually exclusive manner from MED26. Binding 
of the conserved Cdk8 Kinase Module (CKM) generally disrupts and prevents RNA Pol II 
binding via a mechanism that is kinase independent (Knuesel, Meyer, Bernecky, & Taatjes, 
2009). This CKM association causes a structural shift in Mediator and subsequent 
transcriptional repression of target genes. Furthermore, different transcription factors 
interact with different Mediator subunits to orchestrate their transcriptional responses 
(D’Alessio, 2011), contributing to the complexity of the multi-subunit Mediator complex. 
 
3.1. Cdk8’s many roles 
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 The complex of Cdk8 and its kinase module with Mediator is are predominantly 
viewed as a repressor of transcription. However, phosphorylation by Cdk8 is emerging as 
a key regulator of multiple transcriptional programs. Cdk8 has been show to phosphorylate 
an interdomain linker region in Smad transcriptional activator proteins to both start 
transcription and prime the activator for degradation (Alarcon et al., 2009). Cdk8 also 
negatively regulates lipogenesis through phosphorylation of the transcription factor 
SREBP-1c to induce its subsequent ubiquitination and protein turnover (X. Zhao et al., 
2012). The Cdk8 kinase module has also been linked to p53 dependent coactivation of p21, 
where components of the Mediator core have been present at the p21 promoter where Cdk8 
is recruited to (Donner, Szostek, Hoover, & Espinosa, 2007). The Cdk8 kinase module also 
plays a role in the Wnt pathway by both stimulating b-catenin transcription (Firestein et 
al., 2008) and inhibiting the repressive activity of E2F1 towards b-catenin via 
phosphorylation (Morris et al., 2008). HIF1A has been found to recruit Cdk8, Mediator, 
and the super elongation complex for hypoxia inducible gene transcription (Wang et al., 
2013). More importantly, Cdk8 and Cyclin C have been shown to negatively regulate 
Notch via phosphorylation of the intracellular domain (Fryer, White, & Jones, 2004; N. Li 
et al., 2014). In all these regulatory scenarios, Cdk8 regulation was not unlinked from a 
requirement for the Mediator core, as components of the Mediator core have either been 
present or Mediator’s role was not investigated at all. 
However, studies have begun to see evidence of Cdk8 operating independently of 
Mediator in vitro. Although the majority of Cdk8 kinase module appears to be associated 
with various forms of Mediator, up to 30% of Cdk8 may exist in a form independent of 
Mediator (Knuesel, Meyer, Donner, Espinosa, & Taatjes, 2009). Furthermore, MED13 acts 
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as a bridge to connect Cdk8 to the Mediator core, and several studies have divorced Cdk8 
and Cyclin C regulation from Med12 and Med13 regulation, implicating that Cdk8 may be 
able to act independently of the core Mediator complex. Cdk8 mediates embryonic stem 
cell pluripotency, while Med12 has been found to be dispensable for this role (Adler et al., 
2012). Furthermore, Cdk8 and Cyclin C have been shown to regulate different Notch target 
genes in Drosophila than the other two components of the CKM, Med12 and Med13 
(Janody & Treisman, 2011). In this thesis, we contribute to this model of Cdk8 acting 
independently of the Mediator core with an in vivo analysis of Cdk8’s role in negatively 
regulating LIN-12/Notch in VPCs. 
 
3.2. Individual Mediator components in C. elegans 
Mediator is a well-conserved protein complex found in many biological systems, 
and individual components have been found to play important roles in different signaling 
pathways in C. elegans. Many individual components are required for a structurally stable 
and active Mediator complex; loss of these components prevents transcription of important 
developmental proteins and results in embryonic lethality in C. elegans. MDT-14/Med14 
is the backbone of the Mediator core module, connecting the Head, Middle, and Tail 
subunits (Tsai et al., 2014), and loss of this critical protein results in embryonic arrest at 
the 100-cell stage (Shim, 2002). Loss of MDT-6/Med6, MDT-7/Med7, MDT-10/Med10 is 
still detrimental to C. elegans development, but embryos manage to develop to the ~300-
cell stage (Kwon, 1999) 
However, some Mediator components are not essential for C. elegans embryonic 
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development, but are important factors in several regulatory pathways. The Mediator Tail 
subunit components, SUR-2/Med23 and LIN-25/Med24 appear to function together 
downstream of the EGFR-Ras-MAPK pathway in the vulval precursor cells, and are 
required for transcription of the LIN-12/Notch DSL ligands, lag-2, apx-1 and dsl-1, as well 
as the FGF- encoding gene egl-17 (Chen & Greenwald, 2004; Nilsson et al., 1998) Singh 
and Han, 1995; Tuck and Greenwald, 1995; Nilsson et al., 1998; Boyer et al., 1999; Stevens 
et al., 2002). Meanwhile, DPY-22/Med12 is also required downstream of the EGFR-Ras-
MAPK pathway, but plays an inhibitory role in the regulation of the LET-60/Ras pathway 
(Moghal, 2003). While CDK-8 is a negative regulator of b-catenin, the Mediator 
components DPY-22/Med12 and LET-19/Med13 are required downstream of b-catenin to 
promote cell fusion of the hypodermal cells (Yoda, Kouike, Okano, & Sawa, 2005). 
However, DPY-22/Med12, LET-19/Med13, CDK-8, MDT-1.1/Med1, SUR-2/Med23, and 
LIN-25/Med24 have all been found to function in the establishment or maintenance of VPC 
quiescence, while loss of other Mediator components did not seem to affect this process 
(Clayton, van den Heuvel, & Saito, 2008). It is evident that individual components of the 
Mediator complex are not only required at different regulatory steps in the EGFR, Wnt, 
and cell-cycle pathways, but they may also play opposing roles in each pathway.  
 Furthermore, in C. elegans, the Mediator Tail component MDT-15/Med15 is 
unique in its role in lipid metabolism (Taubert, Hansen, Van Gilst, Cooper, & Yamamoto, 
2008). MDT-15/MED15 binds to the nuclear hormone receptor, NHR-49, and sterol 
regulatory element binding protein, SRP-1, to induce fatty acid desaturation (Taubert, Van 
Gilst, Hansen, & Yamamoto, 2006). Other Mediator components do not appear to function 
in this process. Taken together, the Mediator multiprotein complex performs a broad 
 
17 
variety of molecular functions in many different signaling pathways. As Mediator is 
essential for development, whole-organism analyses of many Mediator subunits has been 
difficult, but C. elegans has been and will continue to be a useful model organism in the 
elucidation of Mediator’s different roles in developmental and physiological pathways. 
 
4. Summary of Thesis work 
 Here, I present my work in studying the various aspects of the negative regulation 
of LIN-12/Notch in C. elegans. In Chapter 2, I investigated the cis-regulatory information 
within the LIN-12 intracellular domain and identified several mechanisms required for its 
downregulation. LIN-12 needs to bind to LAG-2/CSL and associated with the nuclear 
complex in order to be degraded. Furthermore, there are two levels of negative regulation 
in the C. elegans vulval precursor cells (VPCs), where SEL-10/Fbw7 induces the 
degradation of the LIN-12 intracellular domain via the canonical PEST sequence in the 
VPCs. In the descendants of the VPCs, a tyrosine and neighboring leucines in the Cterm 
of the LIN-12 intracellular domain form a structural conformation to enable protein 
turnover.  
 In Chapter 3, I conducted an RNAi screen on a hypermorphic lin-12/NOTCH 
mutant to look for novel negative regulators. I checked 249 conserved protein kinases with 
human orthologs, and identified 13 kinases to negatively regulate lin-12. We attempted to 
use transgenes expressing constitutively activated segments of LIN-12 to characterize 
which step each kinase was acting upon in the regulation of LIN-12/Notch. I found 5 of 
the kinases to modulate the LIN-12 intracellular domain, 3 of which may possibly play a 
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role in the endocytosis or trafficking steps in the LIN-12 pathway. However, there were 
several caveats to my findings, which I will discuss in further detail. 
 In Chapter 4, I delve deeper into studying one of the kinases identified in my screen. 
CDK-8 has previously been shown to negatively regulate Notch, but I demonstrate that 
phosphorylation by CDK-8 is required to downregulate LIN-12/Notch activity, along with 
the rest of the Cdk8 kinase module, independently of the Mediator core. Additionally, we 
find that SUR-2/Med23 and LIN-25/Med24 are required for the transcription of LIN-























Figure 1. Conservation of the LIN-12/Notch receptor. 
The LIN-12/Notch receptor is a single-pass transmembrane receptor, with a conserved 
structure in its invertebrate and vertebrate orthologs. The extracellular region of LIN- 
12/Notch consists of EGF repeats, LIN-12/Notch Repeats (LNR), and heterodimerization 
(HD) domains. The intracellular domain of LIN-12/Notch (NICD) contains the RBP-JK 
associated molecule (RAM), ankyrin repeats (ANK), and a PEST sequence. D. 
















Figure 2. LIN-12/Notch signaling pathway 
Binding of DSL ligands triggers LIN-12 activation and subsequent cleavage events: 
metalloproteases of the ADAM family, SUP-17 and ADM-4, mediate site 2 (S2) 
cleavage. The γ-secretase complex, SEL-12 and HOP-1, mediate site 3 (S3) cleavage, 
releasing the LIN-12/Notch intracellular domain (LIN-12(intra)/NICD). The LIN-
12/Notch intracellular domain translocates to the nucleus, and binds to LAG-1, SEL-8, 
and other coactivators to form a nuclear complex that activates target gene transcription. 
SEL-10/Fbw7 is a E3 ubiquitin ligase that mediates LIN-12/Notch intracellular domain 
degradation. 
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Figure 3. SEL-10/Fbw7 mediated degradation of LIN-12/Notch 
 
The E3 ubiquitin ligase binds to a conserved Cdc4 phosphodegron (CPD) in the PEST 
domain of the LIN-12/Notch intracellular domain. The central threonine and +4 serine in 
the CPD are phosphorylated in order for SEL-10/Fbw7 to bind and cause ubiquitination-























Figure 4. C. elegans VPC development 
 
The VPCs start off as multipotent cells with equal potential to adopt the 1°, 2°, and 3° 
cell fates. An anchor cell (AC) in the gonad causes an inductive signal to P6.p, activating 
the EGFR-Ras-MAPK signaling pathway and causing P6.p to adopt the 1° cell fate. 
Subsequent lateral signaling to P5.p and P7.p induces the LIN-12 signaling pathway, 
causing P5.p and P7.p to adopt the 2° cell fate. P3.p, P4.p, and P8.p adopt the default 3° 
cell fate. The specified VPCs then undergo division in a stereotypical pattern, where the 
descendants of P5.p, P6.p, and P7.p go on to form the C. elegans vulva, and descendants 


















Figure 5. Major signaling events in VPC development  
An inductive signal encoded by LIN-3 from the anchor cell (AC) of the gonad activates 
the EGFR-Ras-MAPK pathway P6.p, resulting in 1° fate specification. This leads to the 
expression of a lateral signal composed of DSL ligands that activate the LIN-12/Notch 
pathway, resulting in 2° fate specification in P5.p and P7.p. Low, graded amounts of 
LIN-3 reach P5.p and P7.p, but genes downstream of the LIN-12 signaling pathway 
negatively regulate the EGFR-Ras-MAPK pathway in a positive feedback loop to induce 
the 2° cell fate. 








Chapter 2. Determinants in the LIN-12/Notch 
intracellular domain that govern its activity and 
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Abstract 
Upon ligand binding, the LIN-12/Notch intracellular domain is released from its 
transmembrane tether to function in a nuclear complex to activate transcription of target 
genes.  During Caenorhabditis elegans vulval development, LIN-12/Notch is activated by 
ligand in two of six multipotential Vulval Precursor Cells (VPCs), specifying the “2o vulval 
fate” and descendants that contribute to the vulva.  If LIN-12 is ectopically activated in 
other VPCs, they also adopt the 2o fate, dividing to produce extra vulval cells and resulting 
in a “Multivulva” phenotype.  Here, we identify determinants in the LIN-12 intracellular 
domain that govern its activity and stability during C. elegans vulval development; we 
assayed activity of mutant forms based on their ability to cause a Multivulva phenotype 
and stability using a GFP tag to visualize their accumulation.  Our analysis has revealed 
that, while the ubiquitin ligase SEL-10/Fbw7 promotes LIN-12(intra) downregulation in 
VPCs, there is a distinct mechanism for downregulation of LIN-12(intra) in VPC 
descendants.  Our analysis also revealed that LIN-12(intra) must be in the nuclear complex 
to be regulated appropriately in VPCs and their descendants, and that the structure or 
conformation of the carboxy terminal region influences the stability as well.  Although 
activity and stability are generally well-correlated, exceptions where they are uncoupled 
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suggests that there may be roles for the carboxy terminal region and sel-10 that are 




LIN-12/Notch is a transmembrane protein receptor that is cleaved upon ligand 
binding to release the intracellular domain from a membrane tether.  The liberated 
intracellular domain forms a nuclear complex with a sequence specific DNA binding 
protein called CSL (CBF1, Suppressor of Hairless, LAG-1) and an additional protein, 
Mastermind (SEL-8 in C. elegans).   This nuclear complex activates the transcription of 
target genes.  
The activity and stability of the LIN-12/Notch intracellular domain is regulated 
during normal development and tissue homeostasis, and abrogation of such regulation can 
cause disease (Aster et al. 2008; Belver and Ferrando 2016). This regulation is achieved by 
the interaction of modulatory factors with determinants within the LIN-12/Notch 
intracellular domain.  The best example is afforded by SEL-10/Fbw7 regulation of LIN-
12/Notch in C. elegans and mammals.  sel-10 was found as a negative modulator of LIN-
12/Notch through genetic analysis in C. elegans (Sundaram and Greenwald 1993; Hubbard 
et al. 1997); its ortholog, Fbw7, was subsequently found to be a tumor suppressor that 
contributes to T cell acute lymphoblastic leukemia (T-ALL) via negative modulation of 
Notch1 (Oberg et al. 2001; Wu et al. 2001; Gupta-Rossi et al. 2001). SEL-10/Fbw7 is the 
substrate recognition component of a multiprotein E3 ubiquitin ligase that acts via a 
conserved sequence in the intracellular domain called a Cdc4 phospho-degron (CPD); 
phosphorylation of the CPD of LIN-12/Notch recruits SEL-10/Fbw7, leading to 
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ubiquitination and degradation of the intracellular domain.  Mutation or deletion of the 
CPD increases stability and activity of the intracellular domain, which causes 
developmental abnormalities in C. elegans (de la Cova and Greenwald 2012; Hubbard et 
al. 1997; Li and Greenwald 2010; Mango et al. 1991) and in humans, causes T-ALL (O'Neil 
et al. 2007; Thompson et al. 2007). 
Here, we analyzed determinants affecting the stability of the LIN-12 intracellular 
domain [LIN-12(intra)] in the Vulval Precursor Cells (VPCs), a C. elegans developmental 
paradigm that has provided many insights into the role of Notch in mediating binary cell 
fate decisions during development and into the mechanism of signal transduction by Notch 
(reviewed in Greenwald, 2012).  Our analysis has revealed that, while sel-10 promotes 
LIN-12(intra) downregulation in VPCs, there is a distinct mechanism for downregulation 
of LIN-12(intra) later, after VPC fate specification and cell division.  Both mechanisms 
require association with LAG-1/CSL in the nuclear transcription complex and a previously 
undefined structural motif in the carboxy terminal region, which we term the “Y region.”  
Our analysis further suggests that there may be roles for the carboxy terminal region and 
SEL-10/Fbw7 that are independent of their roles in regulating LIN-12(intra) stability. 
 
Materials and Methods 
Genetic analysis 
The C. elegans Bristol strain N2 was used as the wild type in this study. The LGIII 
mutation pha-1(e2123ts) and LGV mutation sel-10(ar41) were used.  A complete list of 
strains with full genotypes is provided in Supplemental Table S3.  All strains were grown 
at 25°C.  
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To assess the Multivulva phenotype, we picked individual L4 adults containing the 
relevant extrachromosomal array, and scored for the Multivulva phenotype ~24 hours later 
by inspection. Worms with ³2 ectopic pseudovulvae were counted as exhibiting the 
Multivulva phenotype.  To assess LIN-12 protein accumulation, worms carrying 
extrachromosomal arrays were mounted on 2% agarose pads on a slide, immobilized with 
10 mM levamisole in M9, and analyzed using the 63× objective on a fluorescent 
microscope at 600ms exposure time in the GFP channel.  
 
Plasmid construction 
Each LIN-12 construct plasmid was generated by inserting a PCR product of the LIN-12 
segment into a plasmid containing regulatory sequences from the lin-31 gene and the unc-
54 3’ UTR (Tan et al. 1998). The plasmid p874 [lin-31p::lin-12(intra)] was digested with 
BglII and NotI, and the backbone containing lin-31p was isolated and used for all plasmid 
generation. Each LIN-12 segment was individually constructed via PCR and using the 
template p385 [lin-12(cDNA)::GFP]. Fusion PCR methods were used for some constructs. 
PCR fragments were digested with BglII and NotI, then inserted into the backbone 
containing lin-31p via FastLink ligation methods. The plasmids constructed and primers 
used are listed in Supplemental Tables 1 and 2. 
 
Construction of transgenic worms 
All transgenes are complex arrays (Kelly et al., 1994) that were generated by selection for 
rescue in the pha-1(e2123) background (Granato et al. 1994). Each LIN-12 construct 
plasmid was linearized and injected at 1 ng/μL, along with pBX (pha-1(+)) and p716 (myo-
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3p::mCherry) at 1 ng/μL and PvuII-digested N2 gDNA at 50 ng/μL, into 20 pha-
1(e2123ts). Injected P0s were kept at 15° for 3 days, then shifted to 25° for 4 days. 
Independent transgenic lines were isolated from F2s, generating a maximum of one line 
per injected P0. The transgenes generated are included in the genotypes of the strains listed 
in Supplemental Table 3. 
 
Statement on data and reagent availability 
 
 All strains and constructs are available upon request.  Please request strains using the "GS" 
name or plasmids using the "P" designation as in Supplemental Tables S1 and S3. 
 
Results 
Distinct mechanisms for temporal regulation of the stability of the LIN-12 
intracellular domain in Vulval Precursor Cells 
We analyzed determinants affecting the stability of the LIN-12 intracellular domain 
[LIN-12(intra)] in the Vulval Precursor Cells (VPCs).  The VPCs are the six polarized 
epithelial cells, numbered P3.p-P8.p, which have the potential to adopt one of three fates 
depending on the signaling inputs they receive in the L3 stage (Fig.1a, reviewed in 
Sundaram, G&D 2005).  During normal development, P6.p adopts the 1o fate associated 
with activation of an EGF receptor-Ras-ERK cascade; P5.p and P7.p adopt the 2o fate 
associated with activation of LIN-12/Notch; and P3.p, P4.p and P8.p adopt the default, 3o 
fate as in the absence of signaling (Sternberg 2005).    After specification, all six VPCs 
divide to generate daughters (“Pn.px”); the daughters of the 1o and 2o VPCs divide further 
to produce vulval cells, whereas the daughters of the 3o VPCs fuse with the major 
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hypodermal syncytium (Fig. 1A).  Mutations in endogenous lin-12 that cause strong, 
constitutive activation of LIN-12 causes all six VPCs to adopt the 2o fate, resulting in a 
“Multivulva” phenotype (Greenwald et al., 1983).   
In this study, we use regulatory sequences derived from the lin-31 gene and a 
heterologous 3’ UTR (based on Tan et al. 1998) to generate transgenes that express GFP-
tagged forms of LIN-12(intra) in VPCs and their descendants (Fig. 1B).  Under these 
transgene conditions, wild-type LIN-12(intra)::GFP does not cause strong constitutive 
activation because it is not stable.  We therefore can assess if mutant forms (i) have strong 
constitutive activity resulting in the characteristic “Multivulva” phenotype associated with 
ectopic 2o fate, and (ii) are stable based on GFP accumulation in VPCs and their 
descendants. 
The domain structure of the LIN-12 intracellular domain is shown in Fig. 2A.  As 
described below, the amino terminal RAM+ANK domain, a hallmark of all Notch proteins, 
is sufficient to form the ternary complex with LAG-1 and SEL-8 (Wilson and Kovall 2006) 
and promote activation of LIN-12/Notch targets ((Li and Greenwald 2010); see also “LIN-
12(intra∆P)” below).  Following the RAM+ANK domain is a PEST sequence; the term 
“PEST” has been applied in different ways to the carboxy terminal region of Notch, but 
here, we use it to indicate the sequence predicted by the program PESTFIND (Rice et al. 
2000).  In LIN-12, the PEST sequence consists of two motifs:  the aforementioned CPD 
and the “S4” domain, both also present in mammalian Notch proteins.  The CPD is the 
well-characterized phosphodegron targeted by SEL-10/Fbw7 (Welcker and Clurman 
2008); mutational analysis of human Notch1 has shown that the S4 domain may work in 
conjunction with the CPD in regulating the stability of the intracellular domain (Chiang et 
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al. 2006).  We refer to the carboxy terminal region following the PEST sequence in LIN-
12 as “Cterm”; it is not overtly conserved in amino acid sequence between LIN-12 and 
mammalian Notch proteins, but as we show herein, we have identified a sequence within 
the Cterm that influences the stability of LIN-12(intra).   
When we express intact LIN-12(intra) tagged with GFP in VPCs, we do not see 
ectopic 2o fate or visible GFP fluorescence; in contrast, cis-deletion of the PEST+Cterm 
region in the truncated form we have previously called LIN-12(intra∆P) results in strong 
constitutive activity, manifested as a Multivulva phenotype (Li and Greenwald, 2010) (see 
Figs. 2B,C).   Thus, there are negative regulatory elements in the PEST+Cterm region.  One 
of these elements is the CPD; thus, removal of sel-10/Fbw7 also results in a Multivulva 
phenotype.  However, deletion of PEST+Cterm is not equivalent to loss of sel-10 in terms 
of the temporal profile of protein accumulation:  in a sel-10 null [sel-10(0)] background, 
LIN-12(intra)::GFP is stabilized only in VPCs but not their descendants; in contrast, when 
the PEST+Cterm sequence is deleted in cis, the resultant protein is stable in both VPCs and 
their descendants (Fig. 2B,C).  These observations suggest that there are distinct 
mechanisms that govern the temporal stability of LIN-12(intra), and that a sel-10-
independent pathway regulates LIN-12(intra) stability in the VPC descendants.   
We were concerned that this temporal difference might be an artifact of the 
canonical LIN-12(intra)::GFP we first tested.  In the canonical form, GFP replaces a 
sequence between two XhoI restriction sites (Fig. 2A), as in the original GFP-tagged full-
length form of LIN-12 that had been well characterized for its activity and trafficking 
(Levitan and Greenwald 1995; Shaye and Greenwald 2002).  Thus, we restored the 
sequence encoded by the Xho fragment to make LIN-12(intra)::GFP[2], such that GFP is 
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now inserted into an otherwise intact LIN-12(intra) (Fig. 2B).  Three independent 
transgenic lines expressing LIN-12(intra)::GFP[2] had the same properties as transgenes 
that express canonical LIN-12(intra)::GFP:  we did not observe a Multivulva phenotype, 
indicating that the form has low constitutive activity, or visible GFP expression in the 
VPCs, indicating it is not stable.  When we placed LIN-12(intra)::GFP[2] transgenes into 
a sel-10(0) background, the penetrance of the Multivulva phenotype was high and GFP 
was visible in VPCs, but not in their descendants.  Thus, the temporal determinant that 
leads to degradation in VPC descendants was not present in the “missing” sequence, and 
resides in the PEST+Cterm region.   
As a further test, we changed the position of the GFP tag to make LIN-
12(intra)::GFP[3], which has an uninterrupted, intact intracellular domain with the GFP 
fused in frame to the carboxy terminus (Fig. 2C).  As with forms in which GFP is inserted 
within the intracellular domain, LIN-12(intra)::GFP[3] has low constitutive activity and 
low accumulation in VPCs in an otherwise wild-type background, and is enhanced in a sel-
10(0) background to cause both a Multivulva phenotype and accumulation of GFP (Fig. 
2C).  Although there may be modest stabilization in VPC descendants, further analysis 
described below revealed that the carboxy terminus influences stability in VPC 
descendants, suggesting that in LIN-12(intra)::GFP[3], the carboxy terminal GFP tag may 
cause some stabilization.   





The CPD and S4 domains each negatively regulate stability of LIN-12(intra) in VPCs 
but do not affect stability of LIN-12(intra) in VPC descendants  
We tested the role of the conserved amino acid residues in the PEST sequence for their 
effects on stability in VPCs and their descendants.     
 CPD:  LIN-12(intra)::GFP is stable only in VPCs, but not their descendants, in a 
sel-10(0) background.  Mutation of the critical CPD residues--the “central threonine” and 
“+4 serine” (Welcker and Clurman 2008)—to alanine in LIN-12(intra-CPDmut) mimics 
the behavior of a full length LIN-12(intra) in a sel-10(0) background, with strong 
Multivulva phenotype (de la Cova and Greenwald, 2012), and visible GFP in the VPCs but 
not in their descendants (Figs. 2B, 3).  This observation supports the inference that sel-10 
does not mediate the downregulation of LIN-12(intra) in VPC descendants.   
S4:  The S4 domain is a stretch of four serines immediately after the CPD of human 
Notch1; mutation of these serines to alanine stabilizes the Notch intracellular domain 
(Chiang et al. 2006).   C. elegans LIN-12 and its paralog, GLP-1, also have a putative S4 
region (Figure 2A), and mutation of the S4 serines and threonine of LIN-12(intra) to 
alanines [LIN-12(intra-S4mut)], causes a strong Multivulva phenotype and visible GFP in 
the VPCs, but not in their descendants (Fig. 3). Thus, the S4 domain is not required for lin-
12 downregulation in the VPC descendants.   
To test if sel-10-mediated downregulation, which occurs via the CPD, is redundant 
with the S4 domain for downregulation of LIN-12(intra) in VPC descendants, we crossed 
LIN-12(intra-S4mut) transgenes into a sel-10(0) background.   We did not observe 
stabilization of the mutant protein in VPC descendants (Fig. 3), suggesting that the CPD 
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and the S4 domains are not functionally redundant determinants for stability in VPC 
descendants. 
  
The structure of the carboxy terminal region influences stability of LIN-12(intra) in 
VPCs and their descendants 
Since mutation of the CPD and S4 regions did not stabilize LIN-12(intra) in VPC 
descendants, we inferred that other sequences absent from LIN-12(intraΔP) account for its 
stabilization. Indeed, deletion of either the S4+Cterm or just the Cterm region resulted in 
significant stabilization in VPC descendants, indicating that the Cterm region negatively 
regulates the stability of LIN-12(intra) (Fig. 4A,B).  Deletion of the last 48 amino acids 
from the carboxy terminus did not cause a Multivulva phenotype or visible protein 
accumulation (Fig. 4A), indicating that this portion of the Cterm region does not negatively 
regulate LIN-12(intra) stability, and that determinants affecting stability instead reside in 
a 22 amino acid region we refer to here as the “Y” region (Fig. 4A).  The Y region of LIN-
12 does not display overt conservation with Notch proteins from other phyla; however, 
comparison of LIN-12 from three different Caenorhabditis species identified well-
conserved motifs within the Y region to test as potential regulatory sites (Fig. 5A).   
We performed mutagenesis of two conserved stretches containing candidate amino 
acids for post-translational modification: (i) we substituted alanines for the four well-
conserved amino acids “SPEY” and (ii) we generated in-frame deletion of the well-
conserved sequence “TTHTTPTS” (Fig. 5A).  In both cases, the mutant proteins had low 
constitutive activity and were degraded like wild-type LIN-12(intra) (Fig. 5B).  
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In contrast, when we mutated the well-conserved tyrosine Y1375 located between 
these two sequences to alanine, we observed stabilization of LIN-12(intra-Y1375A) 
protein in VPCs and their descendants.  To test if Y1375 serves as a potential 
phosphorylation site, we made the more conservative Y1375F mutation, and found that the 
resulting mutant LIN-12(intra-Y1375F) protein is not stabilized (Figure 5B).  Based on 
these results, we infer that post-translational modification of Y1375 is not important; 
rather, this residue may play a structural role or mediate protein interactions that govern 
LIN-12(intra) stability.  Additional support for this inference comes from the observation 
that mutation of the two conserved leucines flanking Y1375 to alanine also stabilized LIN-
12(intra-L1373A,L1376A) in VPCs and their descendants, albeit to a lesser extent that 
LIN-12(intra-Y1375A) (Fig. 5B).  These results suggest that (i) this conserved region of 
the Cterm is important for its structure, and (ii) the Cterm region influences negative 
regulation of LIN-12(intra) levels in VPCs and their descendants.   
 
Downregulation of the LIN-12 intracellular domain in VPCs and their descendants 
requires assembly of the nuclear complex 
Although deletion of the PEST sequence stabilizes LIN-12(intra) in VPCs and their 
descendants, a deletion of the amino terminus that leaves the PEST sequence intact is 
insufficient to promote turnover in these cells (Fig. 6A), indicating that its ability to do so 
may depend on the context in which it is located or some other property of LIN-12(intra). 
In mammalian cells, phosphorylation of the Notch1 intracellular domain can occur 
in the nuclear complex when it is associated with target DNA, recruiting Fbw7 and leading 
to destruction that ends that transcription event (Fryer et al. 2004).  However, the 
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characterized phosphorylation sites do not correspond to the canonical CPD 
phosphorylation sites that recruit Fbw7 in other substrates (Welcker and Clurman 2008) or 
to the serines of the S4 region, and are not conserved in LIN-12.  Nevertheless, we tested 
the possibility that LIN-12(intra) must be in the nuclear complex to be downregulated by 
mutating the VWMP tetrapeptide motif in the RAM domain of LIN-12(intra) that anchors 
it to LAG-1/CSL in the nuclear complex (Fig. 6) (Wilson and Kovall 2006). Mutation of 
the W and P moieties of this motif to alanine would be predicted to result in an inactive 
LIN-12 intracellular domain since it cannot bind to LAG-1 to form the nuclear complex.  
Indeed, this LIN-12(intra-RAMmut) mutant does not cause a Multivulva phenotype even 
in a sel-10(0) background (Figure 6A).  The LIN-12(intra-RAMmut) protein is stable in 
the VPCs and VPC descendants (Figure 6B), suggesting that LIN-12(intra) has to be in the 
nuclear complex in order to be degraded.  
 
Mutational uncoupling of stability and activity  
As described above, wild-type LIN-12(intra) has low constitutive activity and 
stability in VPCs, and loss of sel-10 concomitantly enhances its constitutive activity and 
stability.   A similar correlation between enhanced constitutive activity (Multivulva 
phenotype) and stability (visible GFP) is seen for most of the mutant forms we describe in 
this study.  However, there are two notable exceptions: (i) when the carboxy terminal 
region after the S4 domain is deleted [LIN-12(intraDCterm] (Fig. 4A), and (ii) when the 
conserved tyrosine has been mutated [LIN-12(intra-Y1375A)] (Fig. 5B).   In both of these 
cases, there appears to be considerable stabilization of the mutant LIN-12(intra-X) protein 
without increasing its constitutive activity, indicating that LIN-12(intra) function is 
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compromised by these alterations in the Cterm region.  Additionally, when we removed 
sel-10(0) activity from each of these two mutants, we observed a strong Multivulva 
phenotype (Fig. 4A, 5B), suggesting that there may be roles for the carboxy terminal region 
and sel-10 independent of their role in LIN-12(intra) stability. 
 
Discussion 
We have shown that there are distinct mechanisms for temporal regulation of the 
stability of the LIN-12 intracellular domain in Vulval Precursor Cells and their 
descendants:  SEL-10/Fbw7 and the PEST sequence, including the individual CPD and S4 
domains within it, negatively regulate stability of LIN-12(intra) in VPCs, but not in VPC 
descendants.  We have also provided evidence that sequences within the carboxy terminal 
region outside of the PEST sequence influences stability of LIN-12(intra) in VPCs and 
their descendants.  This “Y region” is named for a tyrosine moiety that is found in LIN-12 
and its orthologs in other nematode species as well as its paralog GLP-1 in C. elegans, and 
our mutational analysis suggests that it contributes to the structure or mediates protein 
interactions rather than providing a site for post-translational modification per se.  
Furthermore, we have provided evidence that downregulation of LIN-12(intra) in both 
VPCs and their descendants requires its association with the nuclear complex.     
 Most of our manipulations resulted in a consistent correlation between LIN-
12(intra) activity and stability in VPCs:  low constitutive activity and low stability are 
coupled, and high constitutive activity and high stability are coupled.  However, certain 
mutations in the Cterm region uncoupled these properties, resulting in increased stability 
without increased activity.  Since an intact nuclear complex also appears to be prerequisite 
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for downregulation, it is tempting to speculate that the structure of the abnormal Cterm 
region reduces the assembly of the nuclear complex.   Furthermore, although the Cterm 
region is not conserved in terms of primary amino acid sequence between nematode and 
mammalian Notch proteins, our evidence favoring a structural role rather than a specific 
sequence modification raises the possibility that there will be a similar influence in the 
sequence of the carboxy terminus in other Notch proteins, as there are precedents for 
structural similarity between C. elegans and mammalian proteins even when primary 
sequence divergence is too great to detect it (Liu et al. 2008). 
When the LIN-12(intraDCterm) and LIN-12(intra-Y1375A) mutants, which are 
stable but have low constitutive activity, are placed into a sel-10 null mutant background, 
their constitutive activity is increased so as to cause a Multivulva phenotype.  This behavior 
may simply reflect stabilization of the abnormal LIN-12(intra) structure to promote its 
ability to associate with the nuclear complex.  However, we speculate that SEL-10 may 
have a role other than promoting the degradation of LIN-12(intra) per se.  An intriguing 
precedent for an alternative role is provided by the observation that Fbw7 has more than 
one role in the degradation of another of its substrates, Cyclin E:  first, Fbw7 serves as a 
cofactor of the prolyl cis-trans isomerase Pin1 for isomerizing a bond in the Cyclin E CPD, 
with such modification being prerequisite for Fbw7 binding to promote ubiquitination of 
Cyclin E (Yeh et al. 2006).  Another potential precedent is provided by the finding that 
another Fbw superfamily member, β-TrCp1/Fbw1a, is part of a transcription complex that 
includes its substrate b-catenin to enhance transcription of target genes rather than 
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Figure 1.  Wild-type vulval development and the heterologous expression system used.  
A. Schematic representation of the six VPCs, numbered P3.p-P8.p, their daughters 
(Pn.px) and granddaughters (Pn.pxx).  Normally, P6.p adopts the 1o fate associated with 
EGFR activation (red) and P5.p and P7.p adopt the 2o fate associated with LIN-12 
activation (blue).  The Pn.px cells produced by 1o and 2o VPCs undergo additional rounds 
of division.  The Pn.px daughters of 3o VPCs fuse with the major hypodermal syncytium 
and are not present later.  Most Pn.pxx cells undergo one further round of division (not 
shown).   
 
B. Heterologous regulatory sequences from the lin-31 gene (Tan et al., 1998) can be used 
to drive expression of inserted cDNAs in VPCs (top) and their daughters (bottom).  The 
expression system and strain shown is described further in de la Cova and Greenwald 
































Figure 2.  Distinct mechanisms for temporal regulation of the stability of the LIN-12 
intracellular domain in Vulval Precursor Cells.  Here and in subsequent figures, two to 
three extrachromosomal lines were scored for each condition. For assaying activity, we 
scored n = ~100 worms for each line for the Multivulva phenotype. For assaying protein 
stability, we looked at n = 10-20 worms at each stage (Pn.p, Pn.px, Pn.pxx) for each line, 
with a 600ms exposure time.  
 
A. Schematic representation (not to scale) of full-length LIN-12 and LIN-12(intra)::GFP, 
the engineered, tagged canonical form used for most of the analysis in this paper.  The 
“XhoI” segment of full-length LIN-12 has been replaced by GFP in the canonical LIN-
12(intra)::GFP form.  In Fig. 2C, we show that this deletion has no consequence for the 
phenomena we describe here.  Also shown are the amino acid sequences of the CPD and 
S4 domains of the PEST sequence for C. elegans LIN-12 and GLP-1, which can 
functionally substitute for LIN-12 in VPCs (Struhl et al., 1993), and human Notch1. 
 
B. Photomicrographs of phenotypes scored to infer activity and stability.  In an otherwise 
wild-type background, LIN-12(intra)::GFP does not cause an appreciable Multivulva 
phenotype or accumulate visible GFP in VPCs; however, removal of the negative 
regulator sel-10/Fbw7 causes a highly penetrant Multivulva phenotype and visible GFP 
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accumulation.  In every worm with visible GFP, fluorescence is present in most or all 
VPCs.   
We note that the expression system shown in Fig. 1B allows for constitutive lin-
12 activity in the VPCs, but, in contrast to constitutive mutations in the endogenous lin-
12 gene, the somatic gonad is not affected.  Thus, EGFR is activated in P6.p; this 
signaling promotes 1o fate and blocks the effect of constitutive LIN-12, so a normal vulva 
is formed.  The Multivulva phenotype reflects transformation of VPCs that would 
normally have adopted the 3o fate so that they instead adopt the 2o fate.  However, GFP 
fluorescence is seen in all six VPCs, including P6.p, consistent with previous 
observations that the EGFR-mediated block to nuclear LIN-12 is subsequent to nuclear 































Figure 3.  Testing the effect of the position of the GFP tag in LIN-12(intra)::GFP forms.  
In the canonical LIN-12(intra)::GFP, the GFP sequences replace a short segment of LIN-
12 protein encoded by DNA flanked by XhoI sites, represented by the gray box.  As 
shown in A, GFP replaces the XhoI fragment in the canonical form, labeled “intra” here, 
and this sequence is also lacking in the canonical LIN-12DP form that has high 
constitutive activity.  Restoration of this “XhoI” segment, in form LIN-12(intra)::GFP[2], 
does not change the pattern of protein accumulation, indicating that the XhoI segment 
does not contain information that stabilizes LIN-12(intra) in VPC descendents.   
Placement of GFP at the extreme carboxy terminus of full-length LIN-12(intra), in form 





















Figure 4. The CPD and S4 domains mediate stability of LIN-12(intra) in VPCs but do 
not mediate stability of LIN-12(intra) in VPC descendants. Mutation of either the CPD or 
S4 domain prevents degradation of LIN-12(intra), increasing LIN-12(intra) activity and 
protein stabilization in the VPCs. Neither the CPD nor S4 domain contain the regulatory 
information for protein downregulation in the VPC descendants, and loss of sel-10 does 





















































Figure 5. The Cterm region influences the stability of LIN-12(intra). 
 
A. Removing the entire Cterm region in LIN-12(intraDS4+Cterm) and LIN-
12(intraDCterm) stabilizes the intracellular domain in the VPC descendants as well as in 
VPCs.  Deletion of the last 48 amino acids does not affect LIN-12(intra) protein stability 
in VPC descendants, and presence of the first 22 amino acids of the Cterm region is 
sufficient for normal regulation.  We term this 22 amino acid region the “Y region”, after 
a tyrosine moiety that is required for normal regulation (see Fig. 6).  
 
B. The LIN-12(intraD(S4+Cterm)) protein is stabilized in all VPC stages. The GFP is 







































Figure 6. Identification of a sequence that is conserved in LIN-12 of multiple 
Caenorhabditis species that influences LIN-12(intra) stability. 
 
A. The “Y region” is required for downregulation in the VPC descendants and consists of 
the first 22 amino acids of the Cterm. Alignment of the C. elegans, C. briggsae, and C. 
remanei LIN-12 sequences show two well-conserved sequences in that region, 
“TTHTTPTS” and “SPEY,” and the conserved tyrosine highlighted in red, analyzed in 
Fig. 6B. 
 
B. Analysis of conserved regions shown in 6A.  The two well-conserved regions that 
contain amino acids that could serve as sites of posttranslational modification, 
“TTHTTPTS” and “SPEY”, in the Cterm are not required for negative regulation of LIN-
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12(intra) activity or stability of the protein in VPC and VPC descendants. The tyrosine 
between the two regions, Y1375, appears to be structurally important for downregulation 
rather than for a modification such as phosphorylation because, although an alanine 
substitution mutant, LIN-12(intra-Y1375A) is stabilized in VPCs and its descendants, the 
more conservative phenylalanine substitution mutant LIN-12(intra-Y1375F) is not. The 
region around the tyrosine also influences LIN-12(intra) stability, as LIN-12(intra-

























Figure 7. Downregulation of the LIN-12 intracellular domain requires assembly of the 
nuclear complex. The RAM domain contains a tetrapeptide site required for LAG-1/CSL 
to bind to LIN-12(intra) and subsequently form a nuclear complex (Kovall & 
Hendrickson, 2004). Deletion of the RAM+ANK or mutation of the LAG-1/CSL binding 
site prevent LIN-12(intra) from associating with the nuclear complex, which abrogates 













Table S1.  Plasmids generated in this study.  For transgenes generated with these 


























































Table S3.  Strains and transgenes generated in this study.  All constructs express 
forms of LIN-12(intra) tagged with GFP.  Except for “intra[2]” and “intra[3],” the GFP 
tag is inserted as in the canonical “intra::GFP” as described in the text and Fig. 2. 
Name	 Strain	 Construct		 Figure	
GS7374	 pha-1(e2123);	arEx1992	
canonical	intra::GFP	 2	
GS7375	 pha-1(e2123);	arEx1993	 canonical	intra::GFP	 2	
GS8310	 pha-1(e2123);	arEx2427	 intra-CPDmut	 3	
GS8311	 pha-1(e2123);	arEx2428	 intra-CPDmut	 3	
GS8312	 pha-1(e2123);	arEx2429	 intra-CPDmut	 3	
GS8313	 pha-1(e2123);	arEx2430	 intraDS4+Cterm	 4	
GS8314	 pha-1(e2123);	arEx2431	 intraDS4+Cterm	 4	
GS8315	 pha-1(e2123);	arEx2432	 intraDS4+Cterm	 4	
GS8316	 pha-1(e2123);	arEx2433	 intraDCterm	 4	
GS8317	 pha-1(e2123);	arEx2434	 intraDCterm	 4	
GS8318	 pha-1(e2123);	arEx2435	 intraDCterm	 		
GS8323	 pha-1(e2123);	arEx2439	 intraDP	 2	
GS8324	 pha-1(e2123);	arEx2440	 intraDP	 2	
GS8325	 pha-1(e2123);	arEx2441	 intraDP	 2	
GS8326	 pha-1(e2123);	arEx2442	 intraDRAM+ANK	 6	
GS8327	 pha-1(e2123);	arEx2443	 intraDRAM+ANK	 6	
GS8328	 pha-1(e2123);	arEx2444	 intraDRAM+ANK	 6	
GS8332	 pha-1(e2123);	arEx2448	 intra-RAMmut	 6	
GS8333	 pha-1(e2123);	arEx2449	 intra-RAMmut	 6	
GS8334	 pha-1(e2123);	arEx2450	 intra-RAMmut	 6	
GS8335	 pha-1(e2123);	arEx2451	 intra[3]	 2	
GS8336	 pha-1(e2123);	arEx2452	 intra[3]	 2	
GS8337	 pha-1(e2123);	arEx2453	 intra[3]	 2	
GS8338	 pha-1(e2123);	arEx2454	 intra-S4mut	 3	
GS8339	 pha-1(e2123);	arEx2455	 intra-S4mut	 3	
GS8340	 pha-1(e2123);	arEx2456	 intra-S4mut	 3	
GS8341	 pha-1(e2123);	arEx2457	 intra[2]	 2	
GS8342	 pha-1(e2123);	arEx2458	 intra[2]	 2	
GS8343	 pha-1(e2123);	arEx2459	 intra[2]	 2	
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GS8344	 pha-1(e2123);	arEx2460	 intra-SPEYmut	 5	
GS8345	 pha-1(e2123);	arEx2461	 intra-SPEYmut	 5	
GS8346	 pha-1(e2123);	arEx2462	 intra-SPEYmut	 5	
GS8347	 pha-1(e2123);	arEx2463	 intraDTTHTTPTS	 5	
GS8348	 pha-1(e2123);	arEx2464	 intraDTTHTTPTS	 5	
GS8349	 pha-1(e2123);	arEx2465	 intraDTTHTTPTS	 5	
GS8360	 pha-1(e2123);	arEx2476	 intra-Y1375A	 5	
GS8361	 pha-1(e2123);	arEx2477	 intra-Y1375A	 5	
GS8362	 pha-1(e2123);	arEx2478	 intra-Y1375A	 5	
GS8363	 pha-1(e2123);	arEx2479	 intra-Y1375F	 5	
GS8364	 pha-1(e2123);	arEx2480	 intra-Y1375F	 5	
GS8365	 pha-1(e2123);	arEx2481	 intra-Y1375F	 5	
GS8366	 pha-1(e2123);	arEx2482	 intra-LLmut	 5	
GS8367	 pha-1(e2123);	arEx2483	 intra-LLmut	 5	


















We attempted to conduct further analysis regarding whether the S4 domain was 
required for sel-10 mediated degradation of LIN-12(intra) by inducing constitutive LIN-
12(intra) protein turnover via phosphomimetic mutations in the CPD. By mutating the 
threonine and serine in the CPD into glutamic acids, we hoped to induce SEL-10 binding 
and turnover of the LIN-12 intracellular domain. However, the putative phosphomimetic 
mutations behaved like alanine mutations, in that they strongly enhanced LIN-12(intra) 
activity: three extrachromosomal lines containing the LIN-12(intra(actCPD)) transgenes 
all exhibited a high penetrance Multivulva phenotype (Appendix Figure 1A). Surprisingly, 
this glutamate substitutions behaved differently from alanine substitutions in that LIN-
12(intra(actCPD)) was stabilized not only in the Pn.p stage, but also in the Pn.px and 
Pn.pxx stages. Thus, a modification in the charge or structure of the PEST domain can 
affect LIN-12(intra) protein downregulation in the VPC descendants. This may be due to 
structural requirements within the CPD or a more complex model for sel-10/FBXW7 
regulation, where the presence of a phosphorylated CPD is not sufficient, and the kinase(s) 
not only have to phosphorylate the central threonine and +4 serine, but also recruit SEL-
10/Fbw7. It would be interesting to replicate this experiment in cell lines with human 
NICD, to determine if this hypothesis is conserved or restricted to C. elegans. 
Furthermore, nuclear localization of LIN-12(intraDRAM) stabilized it in P3.px, 
P4.px, and P8.px (Appendix Figure 1B), suggesting that turnover of bulk LIN-12(intra) 
protein via the PEST domain may occur in the cytoplasm in VPCs that have adopted the 



































Appendix Figure 1. 
 
A. We tried to induce constitutive sel-10-mediated turnover of LIN-12(intra) using 
phosphomimicking mutations in the CPD (the “intra(actCPD)” construct), but the 
activating mutations actually caused increased lin-12 activity and protein stabilization in 
all VPC stages. Directing the LIN-12(intra) protein into the nucleus did not induce 
protein downregulation; the “nuclear intraDRAM” transgene also expressed GFP in all 
VPC stages. 
 
B. Nuclearization of LIN-12(intraDRAM) prevents protein downregulation in P3, P4, and 
P8. The LIN-12(intraDRAM)::GFP protein is stabilized in Pn.p through Pn.pxx stages in 
P5, P6, and P7, but the protein expression is downregulated in P3, P4, and P8 in the VPC 
descendants. The use of a 2xNLS sequence to direct LIN-12(intraDRAM)::GFP into the 
nucleus stabilizes the protein in P3, P4, and P8. Nuclear LIN-12(intraDRAM)::GFP 














Identification of novel negative regulators of lin-12/NOTCH 
Abstract 
Proper negative regulation of the LIN-12/Notch pathway is crucial for appropriate 
LIN-12/Notch activity, as dysregulation of Notch signaling has been associated with the 
development of several cancers. The tumor suppressor Fbw7 is a negative regulator of 
Notch that was initially identified through genetic analysis in C. elegans. Here, we conduct 
an RNAi screen in C. elegans to identify novel negative regulators of the human Notch 
homolog, LIN-12. We screened 249 conserved protein kinases and identified 13 kinases, 
with a low false positive rate. The 13 kinases consist of CDK-8, which had been previously 
implicated in degradation of human Notch, and 12 novel negative regulators. We attempted 
to characterize which step each kinase acts on LIN-12 in the signaling pathway using 
constitutively activated LIN-12 transgenes. We provide evidence that 5 of our identified 
kinases regulate the LIN-12 intracellular domain. Due to the limitations of our tools, 
adjustments to our methods are required to characterize the kinases further. 
 
Introduction 
Notch is a transmembrane protein that is activated by a ligand of the 
Delta/Serrate/LAG-2 family. The protein subsequently undergoes cleavage in the S2 site 
of the ectodomain through ADAM (a disintegrin and metalloprotease) proteases. γ-
secretase cleaves in the S3 site in the transmembrane domain to release the intracellular 
domain, which acts as a coactivator along with Mastermind in a complex with the CSL 
transcription factor to initiate target gene transcription. Elevated levels of the intracellular 
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domain, caused by mutations that mimic ligand binding or cleavage, can cause cancer due 
to constitutive signaling activity (Roy et al., 2007).  
There are separate but redundant negative regulation mechanisms in the Notch 
pathway to ensure appropriate signal transduction in cells. They act on various levels of 
Notch regulation, from trafficking to intracellular domain turnover. Itch/Su(dx)/WWP-1 
has been shown to control degradation of inactive Notch immediately after early 
endocytosis via polyubiquitination and subsequent lysosomal degradation (Chastagner, 
Israel, & Brou, 2008; Shaye & Greenwald, 2005). Previous findings have implicated that 
Mastermind recruits CDK8 to phosphorylate the Notch intracellular region in the TAD and 
PEST domains to stop transcription and mediate turnover (Fryer et al., 2004). SEL-
10/Fbw7 targets the PEST region of intracellular Notch for ubiquitin-mediated degradation 
(Hubbard et al., 1997). Negative regulation systems like these function efficiently to 
prevent the detrimental effects of abnormal Notch activity, yet much remains to be 
elucidated about each regulation pathway.  
Most cellular pathways have regulatory phosphorylation sites, where kinases are 
required to activate proteins or induce degradation. The intracellular domain of Notch 
contains several of these phosphorylation sites that are required in different regulatory 
mechanisms. A downregulation targeting sequence (DTS) contains serine and threonine 
residues that need to be phosphorylated in order for Notch to be internalized in C. elegans 
(Shaye & Greenwald, 2005). Furthermore, there is fast turnover of the Notch intracellular 
domain due to phosphorylation of the PEST sequence on the C-terminus of the domain. 
The conserved Cdc4 phospho-degron (CPD) is a specific motif in the PEST sequence that 
is targeted for phosphorylation. The phosphorylated CPD recruits the E3 ligase Fbw7 (F-
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box and WD repeat domain-containing 7) to ubiquitinate and degrade the intracellular 
domain (Welcker & Clurman, 2008). The S4 sequence is another highly conserved region 
in the PEST domain that enables regulatory serine phosphorylation events. Mutation of the 
region has been shown to stabilize the intracellular domain and the nuclear complex 
(Chiang et al., 2006). These phosphorylation sites play critical roles in Notch regulation, 
but the kinases responsible for phosphorylating these sites remain unknown.  
C. elegans has proved to be a valuable model for elucidating the core components 
and regulators of the well conserved Notch pathway. Not only have the genes in the lin-12 
pathway molecularly and genetically behaved as found in mammals, constitutive LIN-12 
activity also has detectable consequences in the worm in the form of cell fate changes. 
Thus, the worm provides a simple yet comprehensive way of screening for genetic 
interactions in vivo. Furthermore, RNAi screens also offer a straightforward knockdown 
of individual genes without concern of background alterations from additional genetic 
mutations. By focusing on the 249 conserved protein kinases in C. elegans shown to have 
human orthologs (Shaye & Greenwald, 2011), the negative regulators identified could be 
relevant to cancer pathways known to be associated with alterations in Notch activity. My 
reverse genetics approach will be able to identify novel negative regulators for the further 
elucidation of the lin-12/NOTCH pathway. 
 
Results: 
RNAi screen identifies 14 candidates that potentially negatively regulate lin-12 
In C. elegans, lin-12 acts as a cell fate regulator in the somatic gonad as well as in 
the vulval precursor cells (VPCs). The VPCs are six multipotent cells that originally have 
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the ability to adopt any fate. The anchor cell in the gonad sends an inductive signal to the 
VPC of P6.p lineage to activate the RAS-MAPK cascade. This then inhibits LIN-12 in the 
P6.p VPC, causing the cell to adopt a 1° fate. Lateral signal produced by P6.p induces 
activation of LIN-12 in the neighboring VPCs, P5.p and P7.p, which promotes the 2° fate 
in those two cells. The remaining VPCs – P3.p, P4.p, and P8.p – take on the default 3° fate 
(I. Greenwald, 2005). This 2°-1°-2° fate sequence of the P5.p, P6.p and P7.p VPCs leads 
to descendants that develop into the functional C. elegans vulva, whereas the daughters of 
the 3° fate  cells fuse into the hyperdermis.  
There exists a weak hyperactive mutant of lin-12 with an extracellular-domain 
single base pair mutation that renders the protein constitutively activated (I. Greenwald & 
Seydoux, 1990). This n302 mutation causes sufficiently increased lin-12 activity so that an 
anchor cell does not develop, which leads to an absence of 1° fate induction. However, this 
lin-12(n302) hyperactivity is low enough in the multipotent VPCs such that it is insufficient 
to force them all to adopt 2° fate due to the redundantly negatively regulating pathways 
that suppress the hyperactivity of the mutant LIN-12. Without inductive or lateral 
signaling, these VPCs all take on the default 3° fate. When a negative regulators of lin-12 
is removed in the VPCs of lin-12(n302), such as sel-10, the LIN-12(n302) protein is 
stabilized, allowing it to produce more signal such that the VPCs all adopt the 2° fate and 
each develops into a nonfunctional pseudovulva, giving the worm an observable 
Multivulva phenotype (Figure 1A). This sensitive nature of the lin-12(n302) strain to 
negative regulation of LIN-12 provides a valuable system to screen for novel negatively 
regulating kinases of Notch. 
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RNAi in C. elegans serves as a useful tool for knocking down individual kinases in 
a large-scale screen. The introduction of double stranded RNA requires some time to 
induce the specific degradation of the corresponding mRNA, so feeding L1 worms allows 
us to investigate kinases that are necessary for early larval growth whilst still effectively 
knocking down the kinase in the later stages during VPC development. To ensure that the 
increased activity of lin-12(n302) in the VPCs could be achieved via RNAi, I bleached and 
isolated eggs from lin-12(n302) hermaphrodites and placed them on IPTG plates with sel-
10 dsDNA bacteria to induce RNAi via feeding at 25°C (Timmons, Court, & Fire, 2001). 
Eggs of the same genotype were introduced to GFP RNAi as a negative control. The worms 
were then scored for the Multivulva phenotype as adults. In the presence of the GFP RNAi, 
2% of the lin-12(n302) were Multivulva, whereas 63% of the worms exhibited the 
Multivulva phenotype when exposed to sel-10 RNAi (Figure 1B). In order to enhance the 
effectiveness of the sel-10 RNAi, we made a double mutant of lin-12(n302) with the RNAi 
sensitizer, nre-1(hd20) lin-15b(hd126) (Schmitz, Kinge, & Hutter, 2007). When the 
sensitized strain was subjected to GFP or sel-10 RNAi in the same conditions as described 
before, there was a marked increase in Multivulva penetrance when sel-10 was knocked 
down. GFP RNAi caused a 6% Multivulva phenotype while sel-10 induced 97% 
Multivulva worms (Figure 1B).  
With lin-12(n302); nre-1(hd20) lin-15b(hd126), we would be able to identify 
negative regulators of lin-12 by knocking down one gene at a time. The pool of dsRNA 
tested for the screen comprised the 249 protein kinases that have human orthologs in the 
C. elegans genome. We gathered RNAi clones for 206 of these kinases from the Ahringer 
and Vidal libraries (Kamath & Ahringer, 2003; Rual et al., 2004). An initial check of the 
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accuracy of the library via randomly sequencing 24 of the 206 kinases showed <10% 
erroneous clones. The remaining 43 kinases without readily available RNAi clones were 
personally constructed using PCR. For the screen, each kinase RNAi bacteria clone was 
fed to the C. elegans in triplicate wells, with GFP and sel-10 RNAi serving as negative and 
positive controls, respectively. 
I took a qualitative approach in screening the 249 proteins to produce 14 candidate 
kinases that showed the Multivulva phenotype, indicating successful knock-down of 
kinases that negatively regulated the activity or level of LIN-12 (Figure 2A). I checked for 
penetrance of the Multivulva phenotype of the worms by eye and scored the candidates I 
considered to show a higher Multivulva penetrance than the control. This seemed to 
produce a cut-off of 30% Multivulva worms. The RNAi clones for the 14 identified 
candidates were sequenced and retested on lin-12(n302); nre-1(hd20) lin-15b(hd126) in 
another trial of triplicate wells to ensure the reproducibility of the results (Figure 2A). In 
order to prevent isolation of kinases that were causing a synthetic Multivulval phenotype 
with the lin-15b(hb126) in the sensitizer (Cui et al., 2006), we introduced just nre-1(hd20) 
lin-15b(hd126) worms to the same RNAi for the 14 kinases. Loss of the 14 kinases did not 
generate the Multivulval phenotype, indicating that they were not causing a synthetic 
Multivuval phenotype. 
 
The RNAi screen had a low false positive rate:  13 /14 candidates were validated by 
additional tests 
We used null alleles to genetically verify that the kinases we isolated from our 
screen were negatively regulating lin-12. For the homozygous viable or sterile mutants, we 
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constructed double mutants with lin-12(n302) and scored them for increased lin-12                          
activity in the VPCs. For the kinases kin-20, cdk-8, C24A1.3, and efk-1, the null mutants 
were non-Multivulva in a lin-12(+) background, but exhibited the Multivulva phenotype 
in the lin-12(n302) background (Figure 2B). The null mutants of kinases B0495.2 and hpo-
11 are homozygous sterile, but their homozygous segregants from heterozygous parents 
showed the increased Multivulva phenotype in lin-12(n302). The strong loss of function 
allele mig-15(rh326) and temperature-sensitive par-1(zu310ts) both enhanced lin-12(n302) 
activity despite the non-null nature of the alleles used. Null alleles of the remaining 6 
kinases were larval lethal and thus unable to construct homozygous double mutants with 
lin-12(n302). For verification of these, we constructed RNAi clones that covered non-
overlapping regions of the kinase genes to ensure no off-target effects of the original RNAi 
clone. All of those kinases induced Multivulva phenotypes via RNAi except for wee-1.3 
(Figure 2C). Through mutant alleles and split RNAi, we have confirmed that 13 kinases 
that negatively regulate LIN-12. Furthermore, our results highlight the effectiveness as well 
as the low false positive rate of our RNAi screen. 
 
Five of the identified kinases regulate lin-12 through the intracellular domain 
The hypermorph lin-12(n302) has a missense mutation in the LNR that generates 
ligand-independent activation and cleavage. This means that the kinases we isolated from 
our screen could be regulating lin-12 activity through modulating LIN-12(n302) 
transcription levels, or post-translational modifications, such as membrane trafficking or 
intracellular domain turnover. To identify how our isolated kinases regulate LIN-12, we 
can study the behavior of constitutively activated lin-12 transgenes when each kinase is 
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removed (Figure 3). By using the VPC-specific lin-31 promoter, we can investigate 
kinase regulation of lin-12 without interference from the gonad. By further tagging these 
constructs with GFP, we would be able to not only observe increases in activity levels of 
the LIN-12 segments, but also the stability of the protein via GFP expression in the 
VPCs. 
The intracellular domain of LIN-12 consists of the RAM, ANK, and PEST domains 
(Figure 3); this LIN-12 segment bypasses the S2 and S3 cleavage steps (Struhl et al., 1993). 
The GFP was introduced in place of a short segment flanked by XhoI sites between the 
ANK and PEST domains (Figure 3) (Shaye & Greenwald, 2002)(see also Chapter 2) and 
the construct was inserted into a plasmid containing a VPC-specific promoter, lin-31p  (Tan 
et al., 1998). The lin-31p::lin-12(intra)::GFP transgene is introduced as a stable single-
copy insertion into the genome via the miniMos technique (Frokjaer-Jensen et al., 2014). 
We obtained two independent integrations—arTi24 and arTi43—and evaluated them for 
LIN-12(intra) activity and protein levels.  The lack of a Multivulva phenotype and visible 
GFP accumulation indicate that the activity and level of LIN-12(intra) is being efficiently 
downregulated by preexisting negative regulators in the VPC (Figure 4A). When crossed 
into a sel-10 null mutant, the transgene causes high levels of constitutive lin-12 activity 
due to the VPCs’ inability to degrade the excess intracellular domain. This elevated activity 
and protein level of LIN-12(intra) is evident from the Multivulva phenotype (Figure 4A) 
and GFP expression (Figure 4B). The behavior of LIN-12(intra)::GFP in sel-10(0) 
validates this model for testing for kinase regulation of the intracellular region.  
 Although loss of SEL-10 stabilized LIN-12(intra) protein expressed in strains 
containing each individual transgene to generate an enhanced Multivulva phenotype, loss 
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of cdk-8 had no effect on either of the transgenic lines. We had expected LIN-12(intra) to 
induce the Mulvulva phenotype in cdk-8(0) since cdk-8 has been reported to be required 
for degradation of the Notch intracellular domain (N. Li et al., 2014) (Figure 6A). We 
therefore wondered if the failure to see enhancement resulted from inadequate initial levels 
of LIN-12(intra) resulting from the individual transgenes.  Thus, we combined the two 
independent lines, arTi24 and arTi43, in an RNAi-sensitized background. We conducted a 
RNAi assay of kinase regulation of LIN-12(intra) using the arTi43; arTi24; nre-1(hd20) 
lin-15b(hd126) strain (GS8405), with mCherry RNAi and sel-10 RNAi as negative and 
positive controls, relatively. We determined that combining two transgenic lines increased 
the sensitivity of the LIN-12(intra) construct to loss of negative regulator activity, as cdk-
8 RNAi increased the penetrance of the Multivulva phenotype. With GS8405, we found 
that RNAi knockdown of 5 kinases—cdk-8, kin-3, mig-15, wnk-1, and hpo-11—enhanced 
LIN-12(intra) activity (Figure 4C).   
Next, we wanted to check if these 5 kinases negatively regulated LIN-12(intra) 
activity through the degradation of the intracellular domain protein. We used RNAi against 
the 5 kinases on GS8405, and assayed for GFP expression in the VPCs of L3 worms. sel-
10 RNAi induced visible GFP in the VPCs, but knockdown of the 5 kinase did not stabilize 
GFP accumulation, suggesting that none of the kinases regulate bulk LIN-12(intra) protein 
degradation (Figure 4D). From our RNAi results, we found that cdk-8, kin-3, mig-15, wnk-
1, and hpo-11 negatively regulate LIN-12 through modulating the intracellular domain, but 
not likely through bulk LIN-12(intra) protein degradation per se. 
 
Evidence that the kinases do not regulate lin-12 cleavage or trafficking 
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 Since lin-12(n302) can also be negatively regulated via cleavage and trafficking at 
the membrane, we used a constitutively activated LIN-12 segment that preserved the 
transmembrane domain to investigate if the isolated kinases act on those regulatory steps. 
The lin-12(DE) construct contains the transmembrane and intracellular domains of LIN-12 
with a SEL-1 signal sequence (Grant & Greenwald, 1997) and short ectodomain, and thus 
is subject to ligand-independent activation of LIN-12 (J. Li & Greenwald, 2010; Shaye & 
Greenwald, 2005). This functional LIN-12 fragment will allow us to assay the kinase 
regulation of membrane cleavage and trafficking steps, and we will use GFP accumulation 
to determine protein stability. We obtained two single-copy transgenic LIN-12(DE) 
integrants—arTi46 and arTi54—and put them into a nre-1(hd20) lin-15b(hd126) 
background. Transgenic LIN-12(DE) causes more baseline lin-12 activity than LIN-
12(intra) in the VPCs, since individual transgenes result in a semi-penetrant Multivulval 
phenotype, which is enhanced by loss of SEL-10 (Figure 5A). We conducted an RNAi 
assay of our kinase isolates on arTi46; nre-1(hd20) lin-15b(hd126) and arTi54; nre-
1(hd20) lin-15b(hd126), and observed that loss of kin-3, wnk-1, and hpo-11 increased LIN-
12(DE) activity (Figure 5A). Since regulation of the LIN-12 intracellular domain is still a 
requisite for the lin-12(DE) segment, and we have already observed that kin-3, wnk-1, and 
hpo-11 modulate LIN-12(intra), we speculate that in all 3 cases, the increases in the 
Multivulva phenotype are as a result of—but not limited to—the kinases regulating the 
activity of the LIN-12 intracellular domain. Surprisingly, loss of cdk-8 failed to enhance 
LIN-12(DE) activity. Furthermore, kin-20, csnk-1, and cdtl-7 significantly suppressed the 
Multivulva phenotype, which suggests that they act as a positive regulator of lin-12 
activity. We subsequently looked at how knockdown of kin-3, wnk-1, and hpo-11 affected 
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LIN-12(DE) protein degradation using GFP accumulation, and found no significant 
stabilization of protein levels (Figure 5B). From our assays with transgenic LIN-12(intra) 
and LIN-12(DE), none of the 13 kinases appear to regulate lin-12 strictly through 
membrane cleavage or trafficking. 
 
 
cdk-8 and 4 other kinases affect lin-31 promoter expression 
 Our anomalous results with the lin-31p::lin-12(DE)::GFP transgene prompted us 
to look into other factors within our assay, such as the regulation of the lin-31 promoter. 
sel-10 has been a reliable and well characterized regulator of lin-12 (Hubbard et al., 1997), 
where loss of sel-10 has consistently enhanced LIN-12(intra) and LIN-12(DE) activity, 
expressed in the VPCs. We also know cdk-8 regulates the Notch1 intracellular domain (N. 
Li et al., 2014), but loss of cdk-8 has generated variable results with our LIN-12 transgenes 
that contain lin-31 regulatory sequences. Since the cdk-8(0) allele generates a stronger 
knockdown of cdk-8 than RNAi, we looked at double mutants of cdk-8(0) with arTi24 and 
arTi43 individually, as well as the triple mutant of cdk-8(0) with both lines simultaneously. 
We found that loss of cdk-8 had no effect on the activity of any of those transgenic LIN-
12(intra) combinations (Figure 6A). Furthermore, cdk-8(0) was able to significantly 
suppress the 41% Multivulva phenotype of the transgenic LIN-12(DE) line (Figure 6B). 
We put a single-copy integrant of the transcriptional reporter, lin-31p::2xNLS::YFP, into 
cdk-8(0) and observed that the promoter expression was significantly diminished; lin-31p 
is a consistent VPC promoter where a single copy of the transgene exhibits normal 
expression in 97% of worms, but is only present in 11% of worms in cdk-8(0) (Figure 6C). 
CDK-8 seems to be required for the expression of the lin-31 promoter, and thus for 
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expression of proteins from constructs driven by that promoter, which is consistent with 
our previous findings. There is a significantly reduced amount of lin-31p-driven LIN-
12(intra) and LIN-12(DE) being produced in cdk-8(0), obscuring any effects of reduced 
CDK-8 levels on LIN-12(intra) activity, and actually suppressing the activity of LIN-
12(DE). 
 Applying the same reasoning, we checked if any of our other isolated kinases 
affected lin-31 promoter expression. We made an RNAi-sensitized strain of the lin-31 
transcriptional reporter and conducted RNAi against the kinases on the strain, arTi88; nre-
1(hd20) lin-15b(hd126). Due to the variability of RNAi, we used a stringent criterion for 
scoring lin-31p expression, where we only counted the complete absence of YFP in all the 
VPCs as “off.” With this method, we identified kin-20, cdk-8, csnk-1, cdtl-7, and par-1 to 
affect lin-31 transgene expression (Figure 6D). These findings account for the anomalous 
results with the lin-31p::lin-12(DE)::GFP transgene, where loss of kin-20, csnk-1, and cdtl-
7 appeared to reduce lin-12 activity, when they were in fact just reducing the expression of 
LIN-12(DE). 
 
Wild type LIN-12 affects transgenically-expressed LIN-12(n302) activity 
 Our original RNAi screen was conducted using the lin-12(n302) mutant, which as 
a mutation in the endogenous gene has the lin-12 transcriptional regulatory sequences. 
Before we knew that the lin-31 sequences might be affected, we aimed to determine if any 
of our isolated kinases are just modifying the lin-12 transcript levels by using a transgenic 
lin-31p::lin-12(n302)::GFP, which replaces the endogenous lin-12 promoter and 3’ UTR 
with the VPC-specific lin-31 promoter and ubiquitous unc-54 3’ UTR, respectively. 
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Knockdown of any kinases that result in the enhancement of the activity or protein 
accumulation of this construct will reveal which kinases act on LIN-12(n302) post-
translationally.  
We designed two different lin-31p::lin-12(n302)::GFP constructs, featuring a 
longer 5’ UTR between the lin-31p and lin-12(n302) cDNA that had previously used in a 
egl-17p::lin-12(+)::GFP context (Shaye & Greenwald, 2002), and a shorter 5’ UTR 
extensively used in lin-31p-driven transgenes (de la Cova & Greenwald, 2012). The GFP 
tag is inserted in the region between the XhoI sites in the same manner as LIN-12(intra) 
and LIN-12(DE) transgenes. We obtained two separate, single-copy integrated lines of the 
lin-31p::lin-12(n302)::GFP construct with the longer 5’ UTR, and three separate, single-
copy integrated lines of the transgene with the shorter 5’ UTR. Unfortunately, all five lines 
failed to show enhanced activity in the absence of sel-10, which had strongly increased the 
lin-12(n302) allelic phenotype (Table 1). Furthermore, we constructed a VPC-specific 
LIN-12(n302)::GFP transgene with a 3’ cleavable 2A peptide linker (Ahier & Jarriault, 
2014) attached to a mCherry::H2B; the presence of the mCherry marker provides 
verification that the entire transgenic sequence was translated independent of LIN-
12(n302) regulation and activity. Despite observing the expected mCherry expression in 
the VPCs, the lin-31p::lin-12(n302)::GFP::T2A::mCherry::H2B construct still did not 
exhibit enhanced lin-12 activity in sel-10(0). In all three versions of the LIN-12(n302) 
transgenic lines—alone or in sel-10(0)—we have been unable to visualize the GFP tag. We 
have also confirmed that LIN-12(n302) activity doesn’t affect the lin-31 promoter by 
observing the lin-31p::2xNLS::YFP transcriptional reporter in the lin-12(n302) allele. YFP 
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expression is present in all the VPCs in 100% (n=18) of the worms, indicating that lin-31p 
behaves normally in the hypermorphic lin-12 allele.  
 We hypothesize that LIN-12(n302) activity is reduced by the presence of wild type 
LIN-12 from these findings. We have previously observed that while 100% of homozygous 
lin-12(n302) become Multivulva in sel-10(0) (n=29), 0% of heterozygous lin-12(n302) 
exhibit the Multivulva phenotype in sel-10(0) (n=24). We have witnessed the sensitivity of 
lin-12(n302) to varying levels of regulation, where the lin-12 Multivulval phenotype can 
convey the relative strength of LIN-12(n302) activity with a complete range of 0% to 100% 
penetrance of the Multivulva phenotype. The absence of the strong negative regulator sel-
10 has led to the strong enhancement of all other constitutively activated lin-12 conditions, 
even in the presence of wild type lin-12. Thus, we speculate that the presence of the 
endogenous wild type lin-12 in a heterozygous lin-12(n302) and in transgenic LIN-
12(n302) lines affects the activity of the hypermorphic LIN-12(n302). 
 
Discussion 
In the VPCs, the weak hypermorph lin-12(n302) provides an ideal system to study 
negative regulation of lin-12/Notch. Negative regulatory mechanisms in those polarized 
cells prevent the constitutively activated LIN-12 from inducing 2° cell fate until a negative 
regulator is removed, like the E3 ubiquitin ligase, sel-10. We used the lin-12(n302) system 
to conduct a RNAi screen for novel negative regulators amongst the 249 conserved kinases 
in C. elegans. We isolated 14 kinases that inhibited lin-12/NOTCH activity, and validated 
13 of them as negative regulators using a combination of mutant alleles and split RNAi 
clones. The validation of all but 1 of the isolated kinases highlights the low false positive 
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rate of our screen. We took a semi-quantitative approach in our screen, which may have 
overlooked weak enhancements of lin-12(n302) activity. However, since not every RNAi 
clone was sequenced, and there is natural variability in the strength of RNAi knockdown, 
the identification of 1 previously documented (cdk-8) (N. Li et al., 2014) and 12 novel 
negative regulators of lin-12/NOTCH demonstrates the effectiveness of our RNAi screen 
methodology.  
Furthermore, several of the kinases have previously documented interactions with 
each other, implicating some functional clusters in the regulation of lin-12/NOTCH (Table 
2). cdk-8/CDK8 is the kinase component of the Cdk8 Module, which associates with the 
Mediator complex (Knuesel, Meyer, Bernecky, et al., 2009). B0495.2/CDK11 
phosphorylates the Mediator complex in order for the Cdk8 Module to bind (Drogat et al., 
2012), and CDTL-7/Cdk12 phosphorylates the CTD of RNA polymerase for Mediator 
interaction (Bartkowiak et al., 2010). Additionally, wnk-1/WNK-1 has been found to 
regulate gck-3/GCK-3 in the excretory canal tube formation (Hisamoto et al., 2008), and 
both wnk-1 and gck-3—in  conjunction with hpo-11/NRBP1—are important for outgrowth 
of the excretory cell processes (Shaye, unpublished). Individually removing the majority 
of our kinases only caused semi-penetrant enhancements of lin-12 activity, unlike the 
strong enhancement by loss of sel-10. As a speculative example, sel-10/FBXW7 requires 
phosphorylation at two sites within the CPD in order to bind (Welcker & Clurman, 2008); 
multiple kinases may be required for this phosphorylation process, and loss of a single 
kinase still allows partial degradation of lin-12. Thus, it would be important to study 
simultaneous loss of several kinases, either in the same functional group or in separate 
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groups, to distinguish between the different lin-12 regulatory pathways these kinases may 
act on.  
Our RNAi screen could have revealed genes that act in the regulation of expression, 
trafficking, processing, and stability of LIN-12, so we attempted to characterize which step 
our 13 isolated kinases acted on in the lin-12 pathway. We used lin-31 regulatory sequences 
to drive GFP-tagged transgenic LIN-12 forms in VPCs to look for potential post-
translational regulation by the kinase genes:  enhancement of LIN-12(intra) to identify 
kinases that regulated the intracellular domain, and enhancement of LIN-12(DE) to detect 
kinases  that modified cleavage or trafficking. Since some of our kinases appear to affect 
lin-31 promoter expression, we can parse our findings into three main categories. In the 
first category, three kinases—kin-3, wnk-1, and hpo-11—regulate the LIN-12 intracellular 
activity and not bulk degradation, since loss of those kinases did not appear to affect lin-
31p expression, and they enhanced the LIN-12(intra) activity without overtly stabilizing 
the protein. Those kinases may additionally act on membrane or trafficking steps, as they 
enhanced LIN-12(DE) activity, but we cannot differentiate those possibilities from action 
on LIN-12(intra). Interestingly, despite both wnk-1 and gck-3 being pulled from our RNAi 
screen, and wnk-1 being shown to directly phosphorylate gck-3 (Hisamoto et al., 2008), 
only wnk-1 enhanced the activity of the LIN-12 intracellular domain in our assay. 
Additionally, wnk-1 RNAi enhanced lin-12(n302) activity more than gck-3 RNAi, 
suggesting that wnk-1 may not be regulating lin-12 through gck-3. wnk-1/WNK1 has also 
been implicated in the ERK5 pathway (Xu et al., 2005), which may indicate that despite 
two kinases of the same pathway being identified through our screen, they may be acting 
on lin-12 via different mechanisms. 
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The second category is made up of three kinases—kin-20, csnk-1, and cdtl-7—that 
affect lin-31 promoter expression, appearing to suppress LIN-12(DE) activity, so we cannot 
conclude anything about the level at which they enhance  lin-12(n302). 
 The third category consists of two kinases—cdk-8 and par-1—that are required for 
lin-31 promoter expression, and failed to enhance activity of any lin-12 transgenes.  Since 
they did not suppress the LIN-12(DE) activity either, any enhancements of lin-12 activity 
we visualized may be balanced out by the reduced promoter expression. This hypothesis is 
supported by prior findings that cdk-8 is required for degradation of the intracellular 
domain (N. Li et al., 2014).  
We speculate that the kinases in our second category (kin-20, csnk-1, and cdtl-7), 
as well as the remaining uncategorized kinases (B0495.2, C24A1.3, gck-3, efk-1, and mig-
15) could regulate general lin-12 gene expression levels, since they did not seem to affect 
transgenic LIN-12(intra) or LIN-12(DE) levels. However, we cannot test this hypothesis 
since transgenic LIN-12(n302) does not appear to behave like the other lin-12 forms in the 
presence of endogenous wild type lin-12. Prior studies have linked Notch quality control 
mechanisms to the EGF regions in the ectodomain (Okajima, Xu, Lei, & Irvine, 2005), but 
LIN-12(n302) has an activating mutation in the LNR region, which should bypass any 
excessive protein degradation in the ER. However, we believe wild type LIN-12 may be 
affecting the trafficking of LIN-12(n302) protein in an undetermined manner. Further 
investigation into this phenomenon would require the removal of endogenous LIN-12(+) 
in a LIN-12(n302) transgenic or heterozygous lin-12(n302) background, either by RNAi 
against the XhoI fragment that is absent in the GFP-tagged transgenic forms, or a VPC-
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specific LIN-12(+) depletion experiment using the Cre-Lox system, and then observing for 
any enhancement of LIN-12(n302) activity in sel-10(0). 
Here, we have isolated 13 kinases to negatively regulate lin-12, and attempted to 
identify their levels of regulation. We have proven the effectiveness of our RNAi screening 
methods, which provides a platform for future screens for lin-12 regulation in VPCs. 
Barriers in our tools have prevented us from parsing the kinases into fully characterized 
groups, but we have started to deconstruct the different regulatory systems the kinases can 
modify, with kin-3, wnk-1, and hpo-11 negatively regulating the LIN-12 intracellular 
domain. Modifications to our tools and further investigations into the individual kinases 




Materials and Methods 
C. elegans Genetics 
All strain names and full genotypes are listed in the Supplemental Material. The 
following mutations were used and scored at 20°C:  
LGI: cdk-8(tm1238), par-1(zu310ts), hpo-11(tm4320), efk-1(tm4036) hT2(I;III) 
LGII: B0495.2(gk1202), mIn1 
LGIII: lin-12(n302), C24A1.3(tm364),  rhIs4, oxTi619, unc-32(e189), hT2(I;III) 
LGIV: nT1(IV;V) 
LGV: sel-10(ar41),  
LGX: nre-1(hd20) lin-15b(hd126), arIs116[lst-5p::2xnls-yfp], ZC504.3(tm4151), kin-
20(ok505), mig-15(rh326) 
PCR genotyping techniques were adapted from (Lesa, 2006) to confirm the 
genotype of mutant strains with deletions obtained from the National BioResources 
Project (NBRP).  Strains analyzed in this study, with complete genotypes are listed below 
 
RNAi 
Feeding RNAi was completed as described (Kamath and Ahringer, 2003). Briefly, 
lin-12(n302); nre-1(hd20) lin-15b(hd126) hermaphrodites were grown at 20°C.  Eggs 
were prepared using a bleach/sodium hydroxide protocol and placed on RNAi plates 
containing HT1115 bacteria expressing double-stranded RNA specific for mCherry 
(negative control), sel-10 (positive control), from available Ahringer and Vidal libraries. 
We made RNAi clones for 43 kinases using 1-1.5kb of PCR product for each gene.  We 
made RNAi clones for wee-1.3, csnk-1, cdtl-7, gck-3, kin-3, wnk-1 consisting of PCR 
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products that did not overlap with the RNAi screen clone. Sequences of clones used for 
RNAi experiments were confirmed using Genewiz sequencing services.  RNAi 
experiments were conducted at 25°C. Scoring for the Multivulva phenotype was 
completed three or four days after the egg preparation. 
 
Assessment of Multivulva phenotype 
All double mutant strains containing lin-12(n302) were grown at 20°C. To assess 
the Multivulva phenotype of double mutants, we picked individual L4 adults 
homozygous for the mutations (either grown as a homozygous strain or lost the balancer), 
and scored for the Multivulva phenotype ~24 hours later by inspection.  Confirmation 
that the Multivulva phenotype reflected elevated lin-12 activity based on ectopic 
expression of the lin-12 target gene reporter arIs116 was performed for selected 
genotypes. 
 
Assessment of LIN-12 activity in mutant strains 
Worms with the arIs116[lst-5p::YFP] marker were scored on the fluorescence 
microscope at an 800msec exposure time in the YFP channel. For strains that survived to 
adulthood, they were scored during the L3 Pn.px stage. Each VPC of each worm was 
individually determined to be ON or OFF. Anytime one of the two Pn.px cells was on for 
each VPC, the VPC was counted as ON. 
 
Construction of transgenic strains  
MiniMos plasmids were generated by cutting out the lin-31p from p874[lin-
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31p::lin-12(intra)] with restriction enzymes and inserting them into the backbone 
pCFJ910 from the miniMos plasmid kit (Frokjaer-Jensen et al., 2014). LIN-12 constructs 
were generated using PCR and inserted after the lin-31p.  
arTi24, arTi43, arTi46, arTi54, arTi88, arTi124, arTi125, and arTi126 were generated 
by injecting the respective Minimos plasmids (10 ng/µL) into bristol N2 worms with co-
injection markers pCFJ601 (50 ng/ul), pMA122 (10 ng/ul), pGH8 (10 ng/ul), pCFJ90 (2.5 
ng/ul), and pCFJ104 (5 ng/ul). Worms were grown on G-418 plates and stored at 25°C to 
identify and obtain integrated lines according to the miniMos protocol. 
 
Assessment of LIN-12 protein in transgenic strains 
Worms with a LIN-12 transgene were scored on the fluorescence microscope at an 
1000msec exposure time in the GFP channel. Strains were picked from RNAi plates and 
scored during the early L3 Pn.p stage. Each VPC of each worm was individually 
determined to be ON or OFF. Anytime one of the two Pn.px cells was on for each VPC, 







































Figure 1: The hypermorphic lin-12(n302) produces a multivulva phenotype in the absence 
of the negative regulator sel-10. 
 
(A) Wild type N2 worms normally have one functional vulva (asterisk). lin-12(n302) 
worms are Vulvaless, and produce a Multivulva phenotype in a sel-10(ar41) background. 
 
(B) lin-12(n302) adopts a semi-penetrant Multivulva phenotype in sel-10 RNAi compared 
to control GFP RNAi. The increase in the penetrance of the Multivulva phenotype resulting 
from sel-10 RNAi is significantly increased when lin-12(n302) is in the presence of RNAi 
sensitizer nre-1(hd20) lin-15b(hd126), indicating that RNAi is more effective.  A Student’s 
t-test was used.  
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Figure 2. RNAi screen identified 13 kinases that negatively regulated lin-12. 
 
(A) 14 kinases were identified in the initial screen for enhancement of lin-12(n302). The 
RNAi screen was conducted on lin-12(n302); nre-1(hd20) lin-15b(hd126), with GFP 
RNAi as a negative control and sel-10 RNAi as the positive control. Three RNAi plates 
were prepared and scored for each kinase gene (in the initial screen and all subsequent 
RNAi experiments), and statistical tests were done using a Student’s t-test compared to 
GFP RNAi results. 
 
(B) Null and strong loss of function alleles that were available for each kinase candidate 
was used to verify RNAi screen results. sel-10(ar41) was used as a positive control. The 
kinase mutants were scored alone for the Multivulva phenotype (middle column) and in a 
double mutant with lin-12(n302) (right column). All the kinase mutants enhanced the lin-
12(n302) mutant phenotype with p<0.01 as determined by Fisher’s Exact test compared to 
lin-12(n302) alone.  
The double mutant of lin-12(n302); sel-10(ar41) is homozygous sterile, so the 
homozygous progeny of lin-12(n302)/qC1; sel-10(ar41) him-5(e1490) was scored. The 
mutants B0495.2(gk1202) and hpo-11(tm4320) are homozygous sterile, so the 
homozygous progeny of B0495.2(gk1202)/mIn1 and hpo-11(tm4320)/hT2 are scored for 
strains involving those alleles. Strains with par-1(zu310ts) were grown at 15°C and eggs 
were shifted to 25°C to be scored at the permissive temperature. 
 
(C) Split RNAi clones verified that 5 of the 6 kinases enhanced the lin-12(n302) Multivulva 
phenotype. For the kinases without available alleles, non-overlapping RNAi clones were 
used to verify RNAi screen results. GFP RNAi was used as a negative control, and sel-10 
RNAi was used as a positive control. Since the original kin-3 RNAi clone covered the entire 
cDNA of the kinase, RNAi clones against each half of the kin-3 genome was used. The 
split RNAi clone for each kinase was conducted at the same time as the original screen 
























Figure 3. Segments of LIN-12 expressed using heterologous sequences can in principle 
bypass different steps normally needed to activate LIN-12. 
The RNAi screen is conducted on a strain carrying the lin-12(n302) allele, where a point 
mutation causes ligand-independent activation of LIN-12. The LIN-12(intra)::GFP 
construct bypasses S2 and S3 cleavage steps, but is an active protein that undergoes normal 
intracellular domain regulation. The LIN-12(DE)::GFP undergoes ligand-independent 
activation, which still requires the cleavage and trafficking steps. The LIN-12(n302)::GFP 
construct mimics the lin-12(n302) allele, but with a GFP-tag. All transgenic constructs 













































Figure 4. Transgenic LIN-12(intra) is regulated by sel-10 and 5 kinases. 
 
(A) arTi24 and arTi43 are homozygous single copy insertions of the lin-31p::lin-
12(intra)::GFP transgene. Neither line is Multivulva until the transgene is placed in the 
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sel-10(ar41) background. Fisher’s Exact test was used, compared to the respective strain 
without sel-10(0). 
 
(B) Loss of SEL-10 stabilizes the LIN-12(intra) protein. The GFP-tag on the LIN-12(intra) 
transgene provides a readout of LIN-12(intra) protein, and the GFP is not visible in the 
VPCs until the transgene is placed into a sel-10(ar41) background.  
 
(C) Loss of five of the kinases significantly increased LIN-12(intra) activity. RNAi for the 
kinases was performed on a strain of genotype arTi43; arTi24); nre-1(hd20) lin-
15b(hd126), with mCherry RNAi and sel-10 RNAi as negative and positive controls, 
respectively. Each RNAi clone was done in triplicate and scored for the Multivulva 
phenotype. A Student’s t-test was used, compared to mCherry RNAi results. 
 
(D) The kinases that negatively regulated LIN-12(intra) activity do not affect bulk LIN-
12(intra) protein stability. RNAi against mCherry and sel-10 were used as negative and 
positive controls, and GFP expression was scored in the VPCs at 1000ms exposure time. 
When GFP was visible in the VPCs of a worm, it was present in almost all of the individual 
VPCs. Due to this all-or-none phenotype, the percentage of worms scored with any GFP 












































Figure 5. Transgenic LIN-12(DE) is negatively regulated by sel-10 and three newly 
identified kinases. 
 
(A) Loss of three of the kinases significantly increased LIN-12(DE) activity, and loss of 
three other kinases significantly suppressed the LIN-12(DE) Multivulva phenotype. arTi46 
and arTi54 are homozygous single copy insertions of the lin-31p::lin-12(DE)::GFP 
transgene. RNAi against the kinases was conducted on arTi46; nre-1(hd20) lin-15b(hd126) 
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and arTi54; nre-1(hd20) lin-15b(hd126) with mCherry RNAi and sel-10 RNAi as negative 
and positive controls, respectively. Each RNAi clone was done in triplicate and scored for 
the Multivulva phenotype in two separate experiments. A Student’s t-test was used, 
compared to mCherry RNAi results. 
 
(B) The kinases that negatively regulated LIN-12(DE) activity do not affect bulk LIN-
12(DE) protein stability. RNAi against mCherry and sel-10 were used as negative and 
positive controls, and GFP expression was scored in the VPCs at 1000ms exposure time. 
The percentage of worms scored with any GFP expression in the VPCs is shown. Fisher’s 
Exact test is used, compared to mCherry RNAi results.  
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Figure 6. Loss of some kinases reduces lin-31 promoter expression. 
 
(A) Loss of sel-10 increases LIN-12(intra) activity was scored by the Multivulva 
phenotype. Neither a single transgene of LIN-12(intra) (arTi24 or arTi43 alone) nor 
combining the two transgenes (arTi43; arTi24) exhibited an increase in activity in cdk-
8(0). Fisher’s exact test was used. 
 
(B) The LIN-12(DE) line arTi54 has a semi-penetrant Multivulva phenotype that is 
enhanced by loss of sel-10. In cdk-8(0), LIN-12(DE) activity is suppressed, with a 
significantly lower % of worms showing the Multivulva phenotype. Fisher’s Exact test was 
used. 
 
(C) cdk-8 is required for lin-31 promoter expression. Expression of the lin-
31p::2xNLS::YFP transgene (arTi88) is dimmer in all the VPCs in cdk-8(0), with a 
significantly lower percentage of worms exhibiting “normal” YFP brightness. Worms were 
scored at the Pn.px stage for YFP expression in the VPCs at 1000ms exposure time, with 
4 representative pictures of each strain. 
(D) Loss of five of the kinases reduced lin-31 promoter expression. RNAi was done on the 
RNAi-sensitized lin-31p::2xNLS::YFP transgene, arTi88; nre-1(hd20) lin-15b(hd126). 
Worms were scored at the Pn.p and Pn.px stages for YFP expression in the VPCs; worms 
with YFP in any VPC at 800ms exposure time was counted as “on”. Fisher’s Exact test 



























Table 1. Summary of kinases identified in a screen for enhanced lin-12(n302) activity. 
The 14 kinases isolated from the screen are split into general functional groups. Their 
human orthologs are listed as identified through DIOPT and reverse sequence BLAST. The 













CDK-8 regulates bulk LIN-12(intra) protein via a different mechanism than SEL-10 
 We originally used extrachromosomal arrays of constitutive LIN-12 transgenes in 
our attempt to characterize where the kinases acted on LIN-12/Notch. Each 
extrachromosomal array contained a non-integrated transgenic lin-31p::lin-
12(intra)::GFP with much higher copy numbers of the transgene than the miniMos-
generated single-copy strains we discussed in Chapter 2, thus we observed a low 
penetrance of the Multivulva phenotype, which was enhanced by loss of sel-10. Loss of 
cdk-8 also enhanced the LIN-12(intra) activity (Appendix Figure 1A). However, LIN-
12(intra) protein was stabilized in sel-10(0), but not in cdk-8(0) (Appendix Figure 1B). 
This suggests that SEL-10 and CDK-8 negatively regulate LIN-12 via different 
mechanisms, where SEL-10 mediates degradation of LIN-12 protein, while CDK-8 does 
not affect bulk protein levels. This is contrary to the current model that CDK-8 
phosphorylation is required for SEL-10/Fbw7 mediated turnover of LIN-12/Notch (Fryer 
et al., 2004; N. Li et al., 2014), which is worth further investigation. 
 Unfortunately, we could not meaningfully interpret this experiment with the single-



















Figure A1. sel-10 is required for bulk LIN-12(intra) protein degradation, but cdk-8 is not 
 
(A) Results with arEx1992[lin-31p::lin-12(intra)::GFP] suggested that both sel-10 and 
cdk-8 negatively regulate LIN-12(intra) activity. arEx1992 produces a baseline 31% 
penetrance of the Multivulva phenotype, which is enhanced in both sel-10(0) and cdk-
8(0). Fisher’s Exact was used, compared to arEx1992 alone (+).  
 
(B) Results with arEx1992 suggested that sel-10 causes degradation of bulk LIN-
12(intra) protein, but cdk-8 does not. 27% of worms with arEx1992 express GFP in any 
VPC with an exposure time of 500ms. This LIN-12(intra) protein is stabilized and visible 
in 90% of sel-10(0) worms. Although loss of cdk-8 enhanced LIN-12(intra) activity, it 
did not stabilize LIN-12(intra) protein. Fisher’s Exact was used, compared to arEx1992 
alone (+).   
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Multi-copy integrants derived from LIN-12(intra) extrachromosomal arrays are too 
strong to use for further genetic analysis of the kinase genes. 
 Extrachromosomal arrays are variable in nature, so we decided to integrate our 
extrachromosomal array containing lin-31p::lin-12(intra)::GFP. We used gamma 
irradiation to induce DNA breaks and generated integrated, multi-copy arrays of transgenic 
LIN-12(intra). However, we observed that integrated transgenic LIN-12(intra) presents 
higher activity than in an extrachromosomal array, with a baseline 61% penetrance of the 
Multivulva phenotype (compared to 25% in an extrachromosomal array). The integrated 
array was still sensitive to loss of sel-10 (Appendix Figure 2A) and LIN-12(intra) protein 
levels still aligned with penetrance of the Multivulva phenotype (Appendix Figure 2B).  
 Despite the high baseline Multivulva phenotype, we attempted to use this integrated 
array to determine which of the kinases regulated LIN-12(intra). We put the integrated 
LIN-12(intra) transgene into the RNAi-sensitive background, nre-1 lin-15b, and used 
RNAi to knock down each kinase individually. We observed that loss of 12 of the 13 
kinases seemed to significantly increase LIN-12(intra) activity, which we suspected was 
due to the enhanced nature of the integrated LIN-12(intra) transgene being more sensitive 
to any changes in the VPCs. Around this time, we started employing the single-copy 
miniMos insertion technique.  
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Figure A2. Integrated transgenic LIN-12(intra) is more active than extrachromosomal 
array.  
 
(A) Integration of the extrachromosomal array arEx1992 increased LIN-12(intra) 
activity. arEx1992[lin-31p::lin-12(intra)::GFP] presents a low Multivulva phenotype 
that is enhanced in sel-10(0). arEx1992 was irradiated to obtain the multi-copy integrated 
array arIs234, which presents a higher penetrance of Multivulva worms, which is still 
able to be enhanced by loss of sel-10. 
 
(B) LIN-12(intra) protein stability is comparable to Multivulva phenotype penetrance. 
Loss of sel-10 increased LIN-12(intra) protein stabilization for both the 
extrachromosomal and integrated arrays. 
 
(C) Loss of 12 of the isolated kinases increased activity of the integrated multi-copy LIN-
12(intra) transgene. The integrated array containing lin-31p::lin-12(intra)::GFP was put 
into an RNAi-sensitized background and introduced to RNAi against the 13 kinases 
isolated from the screen (in Chapter 2). Knockdown of 12 of the kinases significantly 
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increased LIN-12(intra) activity. mCherry RNAi and sel-10 RNAi served as negative and 
positive controls, respectively. Each RNAi clone was done in triplicate and scored for the 
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Abstract 
 The Mediator complex that links transcription factors to the basal transcription 
machinery is composed of Head, Middle, and Tail subcomplexes, and may be modulated 
by either the Cdk8 Kinase Module (CKM) or MED26.  We have examined the role of 
individual components of the Mediator complex in the activity of lin-12/NOTCH in 
patterning the fates of the C. elegans Vulval Precursor Cells (VPCs), a process that 
involves the integration of LIN-12/Notch and EGFR signaling. We found that all four 
components of the CKM, and the kinase activity of Cdk8, are required for negative 
regulation of lin-12 activity under conditions where the EGFR patterning input is removed; 
this role, which reflects a potential threshold-setting function in all VPCs, does not require 
most Mediator core components, suggesting that the CKM functions independently of 
Mediator for this role.  In the VPC where EGFR is active, the CKM is not required for 
transcription of lag-2, a ligand needed to activate LIN-12/Notch in neighboring VPCs to 
establish the normal pattern; furthermore, although the Mediator Tail subunits, sur-
2/MED23 and lin-25/MED24, are required for lag-2 transcription, other components of the 





Mediator, a large multiprotein complex consisting of about 26 subunits in 
mammals, links DNA-bound transcription factors to the basal transcription machinery 
(Allen & Taatjes, 2015). Most of the subunits are conserved between yeast and humans, 
and there are additional, metazoan-specific subunits as well.  Based on structural and 
biochemical information, subunits have been assigned to head, middle or tail modules of 
the "core" Mediator complex (Imasaki et al., 2011; Lariviere et al., 2013; Tsai et al., 2014; 
Vojnic et al., 2011), with the most recent assignments based on cryo-EM analysis of yeast 
and human complexes (see Figure 1).    
In addition to biochemical evidence that subsets of components can form 
subcomplexes, genetic analysis of Mediator core genes suggests that some play more 
general roles than others in regulating gene expression.  Mutational analysis has been 
extensively performed in yeast, where it was found that some individual gene knockouts 
are lethal but others are not; the essential genes are more generally required for 
transcription, whereas the non-essential genes have more restricted roles in transcription of 
specific genes (Poss, Ebmeier, & Taatjes, 2013).  Similarly, in C. elegans and Drosophila, 
some Mediator core component genes are essential and others are not (Poss et al., 2013; 
see below).  
There are also regulatory modules that reversibly associate with the core complex.  
Association of the conserved Cdk8 Kinase Module (CKM) generally prevents RNA Pol II 
binding and results in transcriptional repression of target genes, via a mechanism that is 
kinase independent; however, the kinase activity of the CKM can instead promote 
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transcriptional activation (Ansari & Morse, 2013; Bancerek et al., 2013; Nelson, Goto, 
Lund, Hung, & Sadowski, 2003; J. Zhao, Ramos, & Demma, 2013).   A metazoan-specific 
component, MED26, binds to the Mediator core in a mutually exclusive manner to CKM, 
and recruits the Super Elongation Complex to promote activation of target genes 
(Takahashi et al., 2011; Takahashi et al., 2015).  Adding to the complexity of Mediator 
function is the observation that different transcription factors interact with different 
Mediator subunits, allowing different signaling inputs to be converted into different 
transcriptional outputs. 
 The development of the C. elegans vulva involves the integration of multiple 
signaling inputs.  Six Vulval Precursor Cells (VPCs), each have the potential to adopt one 
of three fates; the vulva arises from descendants of cells that adopt the "1o" and 2o" fates.  
In the L3 larval stage, an EGF-like "inductive signal" from the anchor cell of the gonad 
activates a canonical EGFR-Ras-ERK cascade in the nearest VPC, P6.p, causing it to adopt 
the 1o fate.  EGFR also activates transcription of ligands for LIN-12/Notch in P6.p, and 
these ligands activate LIN-12/Notch in the flanking VPCs, P5.p and P7.p, to specify the 2° 
fate.   VPCs in which neither of these pathways is activated adopt the 3o fate.   The 1o and 
2o VPCs divide and generate descendants that form the vulva.  The 3o VPCs produce two 
daughters that do not contribute to the vulva, and instead fuse with the hypodermal 
syncytium.  To achieve this precise spatial pattern, there are multiple negative regulatory 
modes, including mechanisms in all VPCs that set high thresholds for response, and 
mutually inhibitory crosstalk between EGFR and LIN-12/Notch in the presumptive 1o and 
2o VPCs.   
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 The Mediator complex was first implicated in VPC fate patterning by the 
identification of mutations in two genes, lin-25 (now known to encode the ortholog of 
mammalian MED24) and sur-2 (now known to correspond to MED23) (Nilsson et al., 
1998).  Null mutations in these two genes do not affect viability or fertility, and do not 
cause major disruptions in the specification of the 1o fate of P6.p; instead, they are required 
for transcription of the genes encoding ligands for LIN-12/Notch (Chen & Greenwald, 
2004; Zhang & Greenwald, 2011). Other genetic screens implicated the CKM in ectopic 
vulva formation when the EGFR pathway is ectopically activated in VPCs (Clayton et al., 
2008; Grants et al., 2016).  Null mutations in cdk-8 and its regulatory cyclin, cic-1, are 
homozygous viable whereas null mutations in the two other CKM components reveal they 
are essential genes, suggesting that different components of the CKM itself may have 
independent roles.   
   Here, we have examined the contribution of the Mediator core and regulatory 
modules to signaling events that impact LIN-12/Notch activity in VPC patterning.  We find 
that the four components of the CKM act to negatively regulate LIN-12/Notch activity in 
all VPCs whereas individual components of the Mediator core are not required for this 
potential threshold-setting function.  We also find that neither the CKM nor mdt-26/MED-
26 is required for transcription of the lateral signal gene lag-2, necessary for activation of 
LIN-12/Notch in neighboring VPCs.  Although sur-2 and lin-25 are also required for 
transcription of lag-2, many other components of the Mediator core are dispensable for this 
role.   The different requirements for different components of the Mediator complex may 






The Cdk8 module (CKM), but not individual Mediator core complex components, 
are required to negatively regulate activity of LIN-12/Notch in VPCs 
 In this section, we describe the genetic interactions between Mediator components 
and lin-12/NOTCH  in all VPCs, absent input from the anchor cell inductive signal.  In 
sum, our analysis indicates that the CKM acts independently of the Mediator core as a 
negative regulator of LIN-12/Notch in VPCs. 
 lin-12(d) missense mutations cause ligand-independent constitutive activity 
(Sundaram & Greenwald, 1993a).  All lin-12(d) mutants lack an anchor cell, but form an 
allelic series with respect to 2° fate:  in a "weak" lin-12(d) mutant, lin-12(n302), all VPCs 
adopt the 3° fate (like wild-type VPCs when the anchor cell is ablated).  In a "strong" lin-
12(d) mutant, high activity causes all VPCs to adopt the 2° fate, causing a characteristic 
"Multivulva" phenotype.  Loss of a negative regulator such as sel-10/FBXW7 boosts the 
activity of the weak allele enough so that all VPCs adopt the 2° fate instead of the 3o fate 
and the animals become Multivulva.  When lin-12(n302) is combined with the RNAi 
sensitizing background nre-1(hd20) lin-15b(hd126) (Schmitz et al., 2007), potential 
negative regulators that are essential for embryonic development or fertility can be assessed 
by RNAi by directly scoring treated individuals.     
  The enhancement of lin-12(n302) by sel-10(RNAi) to cause a Multivulva 
phenotype in the RNAi-sensitized background offers a paradigm for investigating the role 
of the Mediator complex in LIN-12/Notch signaling, as Cdk8 had been reported to promote 
phosphorylation of the PEST region of the intracellular domain of mammalian Notch 
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within the nuclear complex, thereby recruiting Fbw7 to promote ubiquitination and 
degradation (Fryer et al., 2004).  In addition, Cyclin C, the cyclin that activates Cdk8, is a 
haploinsufficient tumor suppressor via negative regulation of NOTCH1 activity (N. Li et 
al., 2014). Curiously, the phosphorylations attributed to Cdk8 do not correspond to 
canonical residues that promote binding of Fbw7 to its phospho-substrates (Fryer et al., 
2004).    
 Null alleles of cdk-8 are homozygous viable and fertile, and have normal VPC fate 
specification.  Both cdk-8(RNAi) and the null allele cdk-8(tm1238) enhance lin-12(n302) 
activity based on the characteristic Multivulva phenotype of adults and expression of 
arIs116[lst-5p::YFP], a direct transcriptional target of LIN-12/Notch (Figure 2A-D).  In 
addition to Cdk8, the CKM contains Cyclin C, Med12, and Med13. The CKM is capable 
of repressing transcription by the Mediator core independently of its kinase activity; 
however, all four components are critical for repression (Knuesel, Meyer, Bernecky, et al., 
2009). However, components of the Cdk8 Module do not always act together in vivo:  for 
example, in Drosophila, the CDK-8-Cyclin C and Med12-Med13 pairs have both distinct 
and overlapping phenotypes (Loncle et al., 2007), and some target genes require all four 
components whereas other require only the Med12-Med13 pairs (Carrera, Janody, Leeds, 
Duveau, & Treisman, 2008; Janody & Treisman, 2011).  Using enhancement of lin-
12(n302), we were able to assess the role of other components of the CKM and Mediator 
complex. 
 In C. elegans, null alleles of the Cyclin C gene cic-1 are homozygous viable, and 
homozygous dpy-22/MED12 and let-19/MED13 null mutants can be obtained as sterile 
segregants from heterozygotes.  Both RNAi and null alleles of these genes enhance lin-
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12(n302), based on the Multivulva phenotype and arIs116[lst-5p::YFP] expression (Figure 
2B-C).   These results indicate that all four components of the CKM are required for 
negative regulation of lin-12 activity in VPCs and suggesting that they work together in 
this process.  
 Although the CKM can act in concert with the Mediator core complex, it also can 
act independently (Knuesel, Meyer, Donner, et al., 2009).  The Mediator core consists of 
~26 proteins in mammals, divided into the Head, Middle and Tail subcomplexes.  Based 
on extensive biochemical and structural analysis of yeast and mammalian Mediator 
complexes, the current view of this complex and its components, as well as the 
corresponding C. elegans orthologs, is shown in Figure 1.  The Head domain contains the 
most structurally conserved proteins of the three subcomplexes, and is responsible for 
binding to RNA Pol II (Cai et al., 2010). The Middle domain enables Mediator to adopt 
various conformations and anchors the Cdk8 Module (Tsai et al., 2014). The individual 
Tail domain components display the least conservation, and the Tail domain has been 
observed to interact with specific transcription factors (Ansari et al., 2012; Ansari & Morse, 
2012). 
 We tested the requirement for individual components of the Mediator core complex 
using RNAi or null alleles (Figure 2C-D).  Loss or reduction of activity for six components 
of the Head, seven components of the Middle (with caveats for mdt-4 and mdt-31, 
described below), and three components of the Tail, failed to increase lin-12(n302) activity 
based on lack of a Multivulva phenotype (Figure 2C-D).  We corroborated these findings 
using arIs116[lst-5p::YFP] in selected cases as well (Supp. Figure 1). Together, these 
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results suggest that the Head, Middle and Tail subcomplexes are not involved in negative 
regulation of lin-12 in the VPCs.   
 We observed one exception to this general conclusion:  reducing mdt-15/MED15 
by RNAi enhanced LIN-12(n302) (Figure 2D). However, since mdt-15 appears to play 
Mediator-independent roles in C. elegans (Goh et al., 2014; Taubert et al., 2008; Taubert 
et al., 2006), we favor the interpretation that the interaction between this component and 
lin-12 is not indicative of a general role for the Mediator core per se.  
 Finally, we tested MDT-26/Med26, a protein that binds to the Mediator core and 
is found mutually exclusive with the CKM (Davis et al. G&D 2013), using genetic analysis 
of a double mutant with lin-12(n302). Since the null allele mdt-26(tm6272) undergoes L3 
arrest when homozygous, we could only score rare viable "escapers" segregating from mdt-
26(tm6272)/mIn1; lin-12(n302): all six mdt-26(tm6272); lin-12(n302) escapers were non-
Multivulva, suggesting that mdt-26 does not negatively regulate LIN-12 activity.   
 
CDK-8 kinase activity is required for negative regulation of LIN-12/Notch activity 
Although CDK8 has been observed to phosphorylate various substrates (Bancerek 
et al., 2013; Nelson et al., 2003; J. Zhao et al., 2013), CDK8 kinase activity is not required 
for repression of transcription in association with the Mediator core (Knuesel, Meyer, 
Bernecky, et al., 2009). Instead, kinase activity appears to be essential only when the CKM-
Mediator complex promotes transcription of a target (Knuesel, Meyer, Bernecky, et al., 
2009).   Thus, the requirement for kinase activity can differentiate between enzymatic and 
structural roles for the CKM in transcriptional regulation in association with Mediator, and 
perhaps also for Mediator-independent roles of the CKM. 
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A single D173A mutation in a catalytic aspartyl residue in the kinase domain 
completely inactivates the kinase activity of mammalian CDK8 (Akoulitchev, Chuikov, & 
Reinberg, 2000); this residue and its context is conserved in C. elegans CDK-8 (Fig. 3A), 
so the corresponding D182A mutation should lack kinase activity as well.  To investigate 
the requirement for kinase activity, we examined the ability of wild-type or D182A/kinase-
dead CDK-8 expressed in VPCs to rescue the phenotypes associated with loss of the CKM.   
In this section, we explore the requirement of the CKM for negative regulation of 
LIN-12/Notch in all VPCs based on the enhancement of lin-12(n302) to a Multivulva 
phenotype by loss of module components; for this interaction, Mediator core components 
are not required. Multivulva phenotype of cdk-8(0); lin-12(n302).  We found that wild type 
CDK-8 efficiently rescues the Multivulva phenotype of cdk-8(0); lin-12(n302), while two 
independent lines carrying transgenes that express the CDK-8(D182A) kinase-dead mutant 
are not rescued (Fig. 3B).  In these transgenes, we included a fluorescent T2A-linked tag 
(Ahier & Jarriault, 2014) fused to CDK-8 to confirm that the transgene was appropriately 
expressed in VPCs.   The inability of CDK-8(D182A) to rescue the enhancement of lin-
12(n302) by cdk-8(0) supports the inference that the mutation abrogates kinase activity and 
suggests that kinase activity is essential for this role of the CKM. 
 
The CKM and individual Mediator Head and Tail components are not required for 
Notch ligand production  
In C. elegans, the Elk1 transcription factor ortholog LIN-1 is critical for vulval fate 
patterning. One of its roles is to repress lag-2 transcription in P6.p in the absence of EGFR 
signaling; thus, upon induction of P6.p, EGFR-Ras-ERK-mediated phosphorylation of 
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LIN-1/ELK1 relieves repression of lag-2 transcription in P6.p but repression is maintained 
in other VPCs. The Mediator tail components SUR-2/Med23 and LIN-25/Med24 are 
required for lag-2 transcription (Chen & Greenwald, 2004); a simple model based on 
available data is that Mediator acts in conjunction with LIN-39 or another Hox protein to 
promote lag-2 transcription through an activator site adjacent to the LIN-1/Elk1 repressor 
site (Zhang & Greenwald, 2011).  
To determine if other components of the Mediator core complex and the CKM are 
required for lag-2 transcription, we assayed the effect of depleting their activity on the 
expression of the lag-2 transcriptional reporter arIs222[lag-2p::tagRFP].  This reporter is 
strongly expressed in P6.p and its descendants in otherwise wild type worms.  We found 
that this lag-2 reporter is expressed normally in mutants lacking the CKM components cdk-
8 or cic-1, the Head component mdt-28 or mdt-29, and the Mediator Tail component mdt-
15 (Figure 4A-B).  These results point towards a sur-2 and lin-25-specific requirement for 
Notch ligand production that is independent of the rest of Mediator and the CKM. 
For the Middle components mdt-4 and mdt-31, we noted that homozygous null 
mutants segregating from balanced heterozygotes arrest development with defects 
suggesting pleiotropic roles in vulval development.  Based on somatic gonadal morphology 
(partial gonad arm extension with no dorsal turning), the arrest occurs in the early L3 stage; 
the VPCs have not divided in these arrested animals, consistent with an arrest in the early 
L3 stage prior to induction.  These animals fail to express lag-2, but as the somatic gonad 
appears to lack an anchor cell, the source of the EGF-like inductive signal, we cannot 
conclude that these Mediator components are required for lag-2 transcription per se.  The 
potential pleiotropic effects on the state of the VPCs are a caveat to the interpretation of 
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the interpretation of the lack of enhancement of lin-12(n302) described above, based on 
very rare viable escapers that reached adulthood. 
 
De-repression of the block against LIN-12 target lst-5 in P6.p   
We also found that the four components of the CKM are required to block the 
ability of the activated nuclear Notch to promote transcription of 2o targets in a 1o VPC, 
where EGFR is active, a mode of crosstalk between the two pathways. These experiments 




Vulval Precursor Cell (VPC) fate specification requires the integration of EGFR 
and LIN-12/Notch signaling to generate a precise spatial pattern.  In this study, we have 
examined the requirements for components of the Mediator complex and its facultative 
modulators, the Cdk8 Kinase Module (CKM) or MED26, on three different aspects of VPC 
fate patterning that impact LIN-12/Notch activity.  We found different requirements for 
Mediator and its modulators in each of these three different aspects.  Negative regulation 
of lin-12 activity in the absence of EGFR-mediated inductive signal and a block to nuclear 
LIN-12 activity when EGFR is active require activity of the CKM, but differ in their 
requirement for Mediator core subunits.  Transcription of the lateral signal gene lag-2, a 
ligand for LIN-12/Notch, in response to EGFR activation, does not require the CKM and 




Mediator components and negative regulation of lin-12 activity in the absence of 
EGFR-mediated inductive signal. 
In this assay, we used enhancement of the mildly activating mutation lin-12(n302) 
to probe for negative regulatory roles. The lin-12(n302) mutation had two purposes: (i) it 
afforded a sensitized background for observing increased lin-12 activity due to loss of a 
negative regulator and (ii) it removed the cellular source of the EGF signal and hence input 
from EGFR-mediated induction into VPC fate.  Thus, we are assaying for effects of 
Mediator components on a basal level of lin-12 activity that may be important for setting a 
threshold for response to signaling. 
We found that all four components of the CKM act as negative regulators of lin-
12/Notch activity in this assay, but that loss or reduction of activity of Head, Middle, and 
Tail components do not. These observations suggest that the CKM regulates lin-12 
independent of the rest of the Mediator core in negative regulation of lin-12 activity in 
VPCs.  The Tail component mdt-15/MED15 was the sole exception:  we observed that 
reduced mdt-15 activity, like reduced CKM activity, led to increased lin-12(n302) activity.   
Previous genetic studies suggested that mdt-15 may function independently of the Mediator 
core in oxidative stress responses and fatty acid metabolism in C. elegans (Taubert et al., 
2008; Taubert et al., 2006).  Thus, although it remains possible that the Mediator core 
function is not abrogated by removal of individual components, it is tempting to speculate 
that the CKM acts in conjunction with MDT-15 apart from the rest of the Mediator core in 
negative regulation of lin-12 activity in VPCs. 
We further showed that the negative regulatory activity for the CKM in this assay 
appears to require CDK-8 kinase activity.  Since the CKM is stable and biochemically 
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active while apart from Mediator (Knuesel, Meyer, Donner, et al., 2009), and CKM kinase 
activity is not required for the CKM to bind to the Mediator core and block Pol II assembly 
and repress transcription (Knuesel, Meyer, Bernecky, et al., 2009), our results further 
suggest that this canonical role for the Mediator complex is not the basis for negative 
regulation of lin-12 activity by the CKM. 
 
Mediator components and transcription of the lateral signal gene, lag-2. 
EGFR activation in P6.p leads to transcription of lag-2, which encodes a ligand for 
LIN-12/Notch in VPC fate patterning.    Previous work had implicated two Tail 
components, sur-2/MED23 and lin-25/MED24, in transcription of the lateral signal; our 
analysis here suggests that the CKM, Head, and other Tail components, including mdt-15, 
are not required for transcription of lag-2.  The Tail component mdt-15/MED15 connects 
other Tail proteins, including sur-2/MED23 and lin-25/MED24, to mdt-14/MED14, which 
is a central linker of the Mediator core subunits (Tsai et al., 2014).  As above, it is possible 
that several components of the Mediator core have to be removed simultaneously for an 
effect on lag-2 transcription to be manifested.  However, our observations raise the 
possibility that there is a requirement for SUR-2 and LIN-25 that is independent of the rest 
of Mediator and the CKM.  In this regard, we note that SUR-2 and LIN-25 physically 
interact and depend on each other for stability, and null alleles of these genes cause a 
similar phenotype not described for other Mediator component mutants (Tuck papers), 
consistent with this possibility. 
 
Comparison with studies of the CKM and Notch in other systems.    
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Two previous studies of the CKM and Notch are interesting to consider in view of 
the results presented here. (Janody & Treisman, 2011) investigated the role of the CKM in 
the activation of Notch target genes at the dorsal-ventral boundary of the Drosophila wing 
disk.  They found three classes of targets, and proposed a molecular mechanism for each, 
based on their observation that Kohtalo/Med12 and Skuld/Med13 physically associate with 
the DNA binding component of the Notch nuclear complex, Su(H)/CSL.   (1) For a target 
that requires all four CKM subunits for activation, they propose that the CKM forms a 
bridge between the Notch nuclear complex and the basal transcriptional machinery to 
promote activation of the target.  (2) Similarly, for a target that requires only 
Kohtalo/Med12 and Skuld/Med13 for activation, they propose that these two components 
alone form such a bridge.  (3) For a target that requires Med12 and Med13 for repression, 
but not Cdk8 or CyclinC, they propose that Med12 and Med13 are part of the repressor 
complex that is displaced by the Notch nuclear complex, with Notch acting in a permissive 
rather than instructive role through relief of repression rather than promoting activation per 
se. 
In our case, in the assay for enhanced lin-12 activity in the absence of EGFR 
signaling, we mainly used cell fate as our readout, rather than expression of specific LIN-
12/Notch targets per se, but expression of the direct transcriptional target lst-5 correlated 
with the phenotypic findings of 2o fate.  Even so, our genetic results in the lin-12(n302) 
enhancement assay suggest that specification of the 2o fate by LIN-12 requires all four 
components of the CKM and kinase activity and does not require the full Mediator core, 
suggesting a different molecular mechanism in the VPC context than was observed for 
targets at the dorsal-ventral boundary of the Drosophila wing disk. 
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(Fryer et al., 2004) analyzed the regulation of the Notch1 intracellular domain in 
the nuclear complex in cultured mammalian cells.  They found that Cdk8 and Cyclin C 
associates with the Notch nuclear complex, and that Cdk8 phosphorylates the Notch 
intracellular domain to promote its degradation by Fbw7.  Based on these observations and 
other supporting data, they proposed that Cdk8 activity promotes degradation of the Notch 
enhancer complex at target genes.  Their biochemical observations were corroborated in a 
subsequent study, which further showed that in vivo that Cyclin C is a haploinsufficient 
tumor suppressor for the NOTCH1-driven cancer T cell acute lymphoblastic leukemia (Li 
et al. 2014).   Requirements for MED12, MED13, or components of the CKM were not 
examined in either of these studies in mammalian cells. 
Although the intracellular domain of LIN-12/Notch must be able to assemble into 
the nuclear complex to be degraded by SEL-10/Fbw7 (Y.D. and I.G., unpublished 
observations), the Cdk8-dependent phosphorylation of the mammalian Notch1 
intracellular domain occurs at serines that are not conserved in C. elegans LIN-12.  Thus, 





Materials and Methods 
C. elegans Genetics 
All strain names and full genotypes are listed in the Supplemental Material. The following 
mutations were used and scored at 20°C:  
LGI: cdk-8(tm1238), sur-2(ku9), mdt-28(tm1704), mdt-31(tm4681), mdt-1.1(tm1360), 
hT2(I;III) 
LGII: let-19(os33), mdt-4(tm3060), mdt-26(tm6272), mIn1 
LGIII: lin-12(n302), lin-12(n676n930), lin-12(oz48), cic-1(tm3740), mdt-29(tm2893), 
rhIs4, oxTi619, unc-32(e189), hT2(I;III) 
LGIV: nT1(IV;V) 
LGV: sel-10(ar41), sel-10(ok1632), lin-25(ga67), arIs222, nT1(IV;V) 
LGX: nre-1(hd20) lin-15b(hd126), arIs116[lst-5p::2xnls-yfp], dpy-22(e652)  
PCR genotyping techniques were adapted from (Lesa, 2006) to confirm the genotype of 
mutant strains with deletions obtained from the National BioResources Project (NBRP).  




Feeding RNAi was completed as described (Kamath and Ahringer, 2003). Briefly, 
lin-12(n302); nre-1(hd20) lin-15b(hd126) hermaphrodites were grown at 20°C.  Eggs were 
prepared using a bleach/sodium hydroxide protocol and placed on RNAi plates containing 
HT1115 bacteria expressing double-stranded RNA specific for mCherry (negative 
control), sel-10 (positive control), cdk-8, cic-1, dpy-22, mdt-6, mdt-11, mdt-17, mdt-18, 
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sur-2, mdt-4, let-49, mdt10, mdt-21, or mdt-15 from available libraries (Kamath & 
Ahringer, 2003; Rual et al., 2004).  We made RNAi clones for mdt-19, mdt-14, mdt-27, 
and mdt-29 using ~1.5kb of PCR product for each gene.  Sequences of clones used for 
RNAi experiments were confirmed using Genewiz sequencing services.  RNAi 
experiments were conducted at 25°C. Scoring for the multivulva phenotype was completed 
three or four days after the egg preparation. 
 
Assessment of Multivulva phenotype 
All double mutant strains containing lin-12(n302) were grown at 20°C. To assess 
the Multivulva phenotype of double mutants, we picked individual L4 adults homozygous 
for the Cdk8 Module or Mediator core mutant (either grown as a homozygous strain or lost 
the balancer), and scored for the Multivulva phenotype ~24 hours later by inspection.  
Confirmation that the Multivulva phenotype reflected elevated lin-12 activity based on 
ectopic expression of the lin-12 target gene reporter arIs116 was performed for selected 
genotypes. 
 
Assessment of LIN-12 activity in mutant strains 
Worms with the arIs116[lst-5p::YFP] marker were scored on the fluorescence 
microscope at an 800msec exposure time in the YFP channel. For strains that survived to 
adulthood, they were scored during the L3 Pn.px stage. For any strains with the mutants 
mdt-31(tm4681), mdt-4(tm3060), and mdt-26(tm6272)—since they underwent L3 arrest—
they were scored at late L2 Pn.p stage based on gonad size. Each VPC of each worm was 
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individually determined to be ON or OFF. Anytime one of the two Pn.px cells was on for 
each VPC, the VPC was counted as ON. 
 
Assessment of LAG-2 transcription in mutant strains 
Worms with the arIs222[lag-2p::tagRFP] marker were scored on the fluorescence 
microscope at an 500msec exposure time in the RFP channel. For strains that survived to 
adulthood, they were scored during the L3 Pn.px and Pn.pxx stages. The mutants mdt-
31(tm4681), mdt-4(tm3060), and mdt-26(tm6272) were scored at late L2 Pn.p stage based 
on gonad size. Each VPC of each worm was individually determined to be ON or OFF. For 
mdt-31(tm4681) and mdt-4(tm3060), the presence of an Anchor Cell (AC) as marked by 
arIs222 was also scored for each worm. 
 
Protein sequence analysis 
ClustalW2 (http://www.ebi.ac.uk/Tools/msa/clustalw2/) was used to align C. elegans cdk-






































Figure 1. An updated model of the Mediator complex. The Mediator core consists of 
Head, Middle, and Tail subunits, and the C. elegans and human orthologs of each subunit 
component are listed. The C. elegans ortholog pairings in this model are based on 
(Steimel et al., 2013), and subunit  assignment to Head, Middle and Tail subcomplexes 
has been modified based on an updated Mediator cryo-EM structure based on both yeast 
and human complexes (Tsai et al., 2014). The Cdk8 Kinase Module (CKM) reversibly 
binds to the Mediator core via X. mdt-26/MED26 is also found bound to the Mediator 






































Figure 2. Loss of CKM increases LIN-12(n302) activity independent of the Mediator 
core.  (A) Photomicrographs showing that lin-12(n302) itself is not generally Multivulva 
(top), but becomes Multivulva when activity of a negative regulator such as cdk-8 is 
reduced (bottom).   This Multivulva phenotype reflects ectopic 2o fates, confirming that 
the interaction results from increased lin-12 activity (see Supp. Fig. 1).  (B) RNAi 
depletion of sel-10, a negative regulator of LIN-12, enhances lin-12(n302) to a 
Multivulva phenotype in a background sensitized for RNAi by nre-1 lin-15b (see text).  
Results of RNAi for CKM components performed in parallel are also shown.  (C) 
Assessing the effect of null alleles for the CKM and other Mediator components on lin-
12(n302) activity.  (D) Assessing the effect of depleting Mediator components by RNAi 
on lin-12(n302) activity.  











                 
















Figure 3. The kinase activity of CDK-8 is required for negative regulation of lin-
12(n302) activity. (A) ClustalW2 alignment of human and C. elegans CDK-8 show that 
the region required for kinase activity is conserved, including the catalytic aspartate 
residue essential for kinase activity (shaded). (B) Expression of wild type CDK-8 in 
VPCs rescues the Multivulva phenotype of cdk-8(0); lin-12(n302), while two 
independent lines in which the CDK-8(D182A) kinase-dead mutant is expressed in VPCs 
do not rescue.  In both cases, CDK-8 was expressed using regulatory sequences from the 
lin-31 gene and the primary protein product was tagged with T2A- mCherry::H2B to 
























Figure 4. CKM and most of Mediator core is not required for lag-2 transcription. (A) 
The lag-2 reporter arIs222[lag-2p::tagRFP]is transcribed normally in P6.p in mutants 
lacking individual CKM, MED26, Head, and Tail components.  (B) Normal expression of 
the lag-2 reporter in the Anchor Cell of the gonad (arrowhead) and P6.px cells (arrow). 





























Supplemental Figure 1. Cell fate marker confirms that loss of CKM components 
enhances lin-12(n302) activity. The 2° fate marker arIs116[lst-5p::YFP] is a direct 
transcriptional target of LIN-12 and is normally expressed in P5.p and P7.p. In lin-
12(n302), the VPCs all adopt 3° fate and no arIs116 expression is present.  Loss of Cdk8 
Module components cdk-8, cic-1, and dpy-22 resulted in expression of arIs116 in a lin-
12(n302) background. Double mutants of lin-12(n302) with Mediator core mutants mdt-
28, mdt-1.1, mdt-31, lin-25, or mdt-29 did not generate lst-5 expression in the VPCs. 
These experiments confirm that the Multivulva phenotype observed reflects that VPCs 
adopted the 2o fate and that the phenotype-based assay used for most of the analysis in 
















GS7070 cdk-8(tm1238); lin-12(n302); arIs116 
GS7069 cdk-8(tm1238); arIs116 
GS8370 cdk-8(tm1238); arIs222 
GS8371 lin-12(n302) cic-1(tm3740); arIs116 
GS8372 cic-1(tm3740); arIs116 
GS8373 cic-1(tm3740); arIs222 
GS8374 lin-12(n302); dpy-22(e652) arIs116 
GS8375 dpy-22(e652) arIs116 
GS8376 let-19(os33)/mIn1; lin-12(n302); arIs116 
GS8377 let-19(os33)/mIn1; arIs116 
GS8378 mdt-26(tm6272)/mIn1; lin-12(n302); arIs116 
GS8379 mdt-26(tm6272)/mIn1; arIs116 
GS8380 mdt-26(tm6272)/mIn1; arIs222 
GS8381 mdt-28(tm1704); lin-12(n302); arIs116 
GS8382 mdt-28(tm1704); arIs116 
GS8392 mdt-28(tm1704); arIs222 
GS8383 mdt-1.1(tm1360)/hT2; lin-12(n302)/hT2; arIs116 
GS8384 mdt-1.1(tm1360)/hT2; arIs116 
GS8385 mdt-4(tm3060)/mIn1; lin-12(n302); arIs116 
GS8386 mdt-4(tm3060)/mIn1; arIs116 
GS8387 mdt-4(tm3060)/mIn1; arIs222 
GS8388 mdt-31(tm4681)/hT2; lin-12(n302)/hT2; arIs116 
GS8389 mdt-31(tm4681)/hT2; arIs116 
GS8390 mdt-31(tm4681)/hT2; arIs222 
GS8391 mdt-15(tm2182); arIs222 
GS8393 lin-12(n302) mdt-29(tm2893); arIs116 
GS8394 mdt-29(tm2893); arIs116 
GS8395 mdt-29(tm2893); arIs222 
GS8396 lin-12(n302); lin-25(ga67); arIs116 
GS8397 lin-25(ga67); arIs116 
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GS8398 sur-2(ku9); lin-12(n302) 
GS8399 cdk-8(tm1238); lin-12(n302)/qC1; arIs116/+ 
GS8400 lin-12(n302)/qC1; sel-10(ar41) him-5(e1490) 
GS8401 arIs222; arIs116 nre-1 lin-15b 
GS8415 cdk-8(tm1238); arTi117; lin-12(n302) 
GS8416 cdk-8(tm1238); lin-12(n302) -- control 
GS8445 cdk-8(tm1238) arTi43 
GS8446 cdk-8(tm1238) arTi43; arTi24 
GS8447 cdk-8(tm1238); arTi120; lin-12(n302) 
GS8448 cdk-8(tm1238); arTi121; lin-12(n302) 
 
 
Supplemental Table 1. Strains used. Caenorhabditis elegans var. Bristol strain N2 was 












lst-5 is expressed in all VPCs in the absence of mdt-4 and mdt-26 
 lst-5 is a target of LIN-12 and normally expressed when LIN-12 is active in P5.p 
and P7.p. In hypermorphic lin-12 mutants, where all the VPCs adopt the 2° cell fate and 
produce the Multivulva phenotype, the reporter arIs116[lst-5p::2xNLS::YFP] is turned on 
in all 6 VPCs. In the other Mediator mutants described in Supp. Figure 1, we observed wild 
type patterning of lst-5. However, in mdt-4(tm3060) and mdt-26(tm6272), lst-5 is 
ectopically expressed in P3.p, P4.p, P6.p, and P8.p (Figure A,C).  
Here, we do not believe that ectopic arIs116 in mdt-4(tm3060) is a read-out for 
LIN-12 activity per se, since the presence of hyperactive LIN-12(n302) in mdt-4(tm3060) 
actually seems to suppress the expression of lst-5, both in penetrance and brightness of the 
reporter (Figure B, B’). Also, loss of mdt-26 does not appear to enhance lin-12(n302) 
activity (described earlier in the Chapter). In lin-1(0), both 1° and 2° cell fate markers are 
expressed in all the VPCs, while the VPCs only seem to adopt a presumptive 1° cell fate 
(Beitel et al., 1995; Tiensuu, Larsen, Vernersson, & Tuck, 2005). lin-1 mediates the 
repression of lag-2 (Zhang & Greenwald, 2011), so it’s possible that lin-1, along with mdt-
4 and mdt-26, are required for repression of lst-5, independent from negative regulation of 
lin-12.  
We do not believe mdt-4 and mdt-26 are required for all of lin-1’s repressive roles 
in VPC patterning, as lag-2 was expressed normally in P6.p in mdt-26(tm6272) and absent 
in mdt-4(tm3060). Further experiments are required to investigate whether mdt-4 and mdt-




















Figure A2. lst-5 is activated by loss of mdt-4 and mdt-26. (A, A’) The 2° fate marker 
arIs116[lst-5p::YFP] is strongly expressed in Mediator Middle component mdt-
4(tm3060). (B, B’) Compared to in mdt-4(3060) alone, lst-5 expression in mdt-
4(tm3060); lin-12(n302) is actually less prevalent in the VPCs despite the presence of a 
weakly hyperactive LIN-12 form. (C) In mdt-26(tm6272), we observe a similar abnormal 
stabilization of arIs116, but primarily in P6.p and less prevalent in P3.p, P4.p, and P8.p. 
(D) While arIs116 is expressed at a higher penetrance in P3.p, P4.p, and P8.p in the 
double mutant mdt-26(tm6272); lin-12(n302), we don’t see evidence of enhanced LIN-12 




lag-2 transcription is absent in Mediator Middle mutants 
We did observe that LAG-2 transcription is absent from P6.p when the Middle 
components mdt-4 and mdt-31 are removed. However, mdt-4 and mdt-31 null mutants are 
obtained as sterile segregants from heterozygotes, and exhibit pleiotrophic phenotypes, 
including L3 arrest and absence of LAG-2 from the anchor cell (Figure 4B’). This differs 
from the LAG-2 transcriptional requirement for sur-2/MED23 and lin-25/MED24, as they 
do not affect the anchor cell (Chen & Greenwald, 2004). Lack of an anchor cell would 
prevent fate specification in the VPCs, and subsequently, P6.p would not express LAG-2. 
We postulate that mdt-4 and mdt-31 play a role in anchor cell specification, and are not 
required for Notch ligand production per se, but further experiments are needed to 
differentiate the two theories. We can use the anchor cell reporter arIs51[cdh-3p::GFP] to 
confirm our theory and check for anchor cell specification in mdt-4 and mdt-31 mutants. 
We can also conduct tissue-specific rescue of mdt-4 and mdt-31 in the gonad to possibly 





















Figure 4. lag-2 transcription is absent in mdt-4(0) and mdt-31(0). (A) The lag-2 reporter 
arIs222[lag-2p::tagRFP]is not transcribed in P6.p in mutants lacking mdt-31 and mdt-4, 
while it is transcribed normally in CKM, Head, and Tail components (as previously 
discussed).  (B) Normal expression of the lag-2 reporter in the Anchor Cell of the gonad 
(arrowhead) and P6.px cells (arrow). (C) Middle component mutants mdt-4(tm3060) and 
mdt-31(tm4681) lack lag-2 expression in the somatic gonad; there may be no Anchor Cell 
to generate an inductive signal, resulting in the absence of lag-2 expression in P6.p and 














In my thesis, I have investigated several aspects of the negative regulation of LIN-
12/Notch in C. elegans. In Chapter 2, I determined that the LIN-12/Notch intracellular 
domain needs to bind to LAG-2/CSL and associate with the nuclear complex in order to be 
degraded. Furthermore, there are two different mechanisms of negative regulation in the 
C. elegans vulval precursor cells (VPCs), where in the VPCs, SEL-10/Fbw7 induces the 
ubiquitin-mediated degradation of the LIN-12 intracellular domain via the canonical PEST 
sequence. In the descendants of the VPCs, I have identified a tyrosine and neighboring 
leucines in the Cterm of the LIN-12 intracellular domain that form a structural 
conformation that enable protein turnover. 
 In Chapter 3, I conducted an RNAi screen on a hypermorphic lin-12/NOTCH 
mutant to identify 13 conserved kinases that negatively regulate lin-12, of which 12 kinases 
were novel negative regulators. I attempted to characterize which step each kinase was 
acting upon in the regulation of LIN-12/Notch, and found that 5 of the kinases modulate 
the LIN-12 intracellular domain, 3 of which may possibly play a role in the endocytosis or 
trafficking steps in the lin-12 pathway. However, due to the limitations of the tools I used, 
I was unable to fully characterize the regulatory step of each kinase. 
 In Chapter 4, I focus my investigation on one of the kinases from my screen, CDK-
8, which has previously been shown to negatively regulate Notch. I determined that 
phosphorylation by CDK-8 is required to downregulate LIN-12/Notch activity, along with 
the rest of the Cdk8 kinase module, independent of the Mediator core. Additionally, I find 
that SUR-2/Med23 and LIN-25/Med24 activate the transcription of LIN-12/Notch ligand, 




LIN-12(intra) is downregulated in the nuclear complex 
 While many direct negative regulators of lin-12 have been identified, the 
physiological conditions of these interactions are still unclear. In Chapter 2, we provided 
evidence that the LIN-12 intracellular domain needs to be in the nuclear complex with lag-
1 in order to be downregulated. The PEST domain is not sufficient for the degradation of 
LIN-12(intra), and mutating the LAG-1 binding site stabilized LIN-12(intra) protein in the 
VPCs and VPC descendants. Unfortunately, we were not able to determine if being in the 
nuclear complex was a prerequisite for negative regulators to bind to the LIN-12 
intracellular domain. The LIN-12(intra(LAG-1b)) protein stability produced too penetrant 
of a phenotype to be further enhanced by loss of the known negative regulator sel-10. In 
that regard, integrated transgenic lines would be useful, as we would be able to better 
quantify protein stability (e.g. via the brightness of the GFP or via a western blot) to look 
for increased stabilization of any LIN-12(intra) protein beyond our current method. Our 
findings indicate that—at least in some contexts—the LIN-12/Notch intracellular domain 
must be present in the transactivating complex with LAG-1/CSL for subsequent 
degradation. 
 
sel-10 induces LIN-12(intra) degradation in the VPCs 
 The E3 ubiquitin ligase sel-10/FBXW7 has been well studied to bind to LIN-
12/Notch via the CPD and cause its subsequent degradation (Welcker & Clurman, 2008). 
Thus, we used inactivation of the CPD and removal of sel-10 to manipulate the transgenic 
LIN-12(intra) levels. In C. elegans, strong lin-12 activity in the VPCs causes them to adopt 
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the 2° cell fate, discernable by the Multivulva phenotype of the worm. Using this system, 
we found that sel-10 only appears to be important for the negative regulation of lin-12 
before the VPCs have specified, as loss of sel-10 strongly increases LIN-12(intra) activity 
and protein level in the VPCs, but not the VPC descendants. Unfortunately, we were not 
able to make a constitutively downregulated version of LIN-12(intra), as phosphomimetic 
mutations of the CPD actually prevented the degradation of LIN-12(intra). This may be 
due to a more complex model for sel-10/FBXW7 regulation, where the presence of a 
phosphorylated CPD is not sufficient, and the kinase(s) not only have to phosphorylate the 
central threonine and +4 serine, but also recruit SEL-10/Fbw7. It would be interesting to 
replicate this experiment in cell lines with human NICD, to determine if this hypothesis is 
conserved or restricted to C. elegans. 
 We also demonstrated that there exists a conserved “S4 domain” in C. elegans LIN-
12/Notch, as mutation of the presumptive S4 domain stabilized LIN-12(intra) and 
increased its activity. Like the CPD, the S4 domain was important for downregulation of 
the LIN-12 intracellular domain in the VPCs, which led us to suspect that the sequence 
played a role in sel-10 mediated degradation of LIN-12(intra). Although we were not able 
to assay for additive effects of expressing the LIN-12(intraDS4) transgene in sel-10(0) due 
to the high activity strength of the transgene, we did observe that the combination was still 
not able to stabilize the LIN-12 intracellular domain protein in the descendants. Prior 
research has noted that mutations of both the CPD and S4 domains in human NICD did not 
present additive effects compared to single mutations (Broadus et al., 2016), supporting 
our speculation that the CPD and S4 domains may be required in the same pathway. 
However, our tools were not sufficient to make any concrete conclusions, and this would 
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be another case for using integrated transgenes in C. elegans to observe increased protein 
stabilization, as described above.  
 
Structural requirements for LIN-12(intra) downregulation in the VPC descendants 
 After the VPC fates are specified, they undergo division to become VPC 
descendants that eventually form the functional vulva and hypodermis (Sternberg, 2005). 
We determined that there was an additional temporal level of regulation of the LIN-12 
intracellular domain, whereby the protein was downregulated via a different mechanism 
than sel-10 only after the VPC fates are specified. Disruption of this regulation system 
appears to have diminished effects on VPC cell fate specification compared to loss of sel-
10, indicating that this regulation is restricted to the VPC descendants. Since the VPC fates 
were already determined, we were not able to use the Multivulval phenotype as an assay 
for whether the stabilized LIN-12(intra) protein in the VPC descendants were active; a 
direct lin-12 reporter (i.e. driven by lst-5p) would be useful in this analysis.  
This novel mechanism of LIN-12(intra) protein downregulation requires a specific 
structural conformation formed by a “LNYL” sequence in the PEST domain. We also 
observed that tagging the C-terminus with GFP and modifying the charge of the CPD can 
affect this downregulation of LIN-12(intra) in the VPC descendants, indicating the 
importance of the overall structure of the C-terminal end of the LIN-12 intracellular 
domain. Furthermore, this downregulation process may sometimes require LIN-12(intra) 
being in the nuclear complex, as our transgenes that could not bind to LAG-1 presented 
stabilized proteins in the VPC descendants. However, we did observe that a cytoplasmic 
PEST domain is sufficient for downregulation of the protein in VPCs that have adopted the 
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3° cell fate, suggesting a divergent protein degradation process in the VPC descendants 
that doesn’t require LIN-12(intra) being in a nuclear complex.  
Our manipulations of transgenes in the C. elegans VPCs have provided us with 
several insights into the negative regulation of the LIN-12 intracellular domain. While 
some of our findings appear specific to the C. elegans Notch pathway, we have also 
established that conserved regulatory regions in LIN-12 behave the same way as in human 
Notch, and even provided evidence that the LIN-12 intracellular domain must be in the 
nuclear complex for degradation. Beyond the use of more optimized C. elegans tools, such 
as integrated transgenic arrays, it will be important to conduct similar experiments in cell 
culture or a mouse model to verify some of the novel regulatory mechanisms described in 
this chapter. However, the power of the techniques we used in this chapter substantiate C. 
elegans as a fantastic model for studying human Notch regulation. 
 
Novel trans-acting negative regulators of LIN-12/Notch 
The LIN-12/Notch signaling pathway specifies the 2° cell fate in the C. elegans 
VPCs, and high lin-12 activity can induce the Multivulva phenotype. In the weak 
hypermorph lin-12(n302), there are redundant downregulation mechanisms in the VPCs to 
prevent the constitutively activated LIN-12 from inducing 2° cell fate until a negative 
regulator is removed, like the E3 ubiquitin ligase, SEL-10.. Using this system in lin-
12(n302), we conducted a RNAi screen for novel negative regulators amongst the 249 
conserved kinases in C. elegans. Our screen had a low false positive rate and effectively 
identified 13 negative regulators of lin-12/NOTCH, consisting of one previously published 
negative regulator, cdk-8, and 12 novel kinase regulators.  
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Since our RNAi screen could have revealed genes that act in the regulation of 
expression, trafficking, processing, and stability of LIN-12, we attempted to characterize 
which step our 13 isolated kinases acted on in the lin-12/NOTCH pathway. While we could 
not make the scope of conclusions we originally intended to due the limitations of the tools 
we used, we can at least report three kinases—kin-3, wnk-1, and hpo-11—to regulate the 
LIN-12 intracellular activity and not bulk degradation, and possibly also act on membrane 
or trafficking steps, but we cannot differentiate those possibilities from action on LIN-
12(intra). We can also propose that two kinases—cdk-8 and par-1—may also negatively 
regulate LIN-12 intracellular domain, since any enhancements of lin-12 activity we 
visualized in the absence of these kinases may be balanced out by the reduced promoter 
expression. However, that conclusion will require further experimentation with a promoter 
that is not regulated by the two kinases. 
While our screen and experiments have provided us with bountiful insight into this 
group of negative regulators of lin-12/NOTCH, it’s also important to delve into the 
complications of lin-12/NOTCH activity in different cellular contexts. We have observed 
that LIN-12(n302) can exhibit greater LIN-12 activity in the gonad than stronger 
hypermorphic alleles, but exhibit less lin-12 activity than the same hypermorphic alleles in 
the VPCs. This highlights the importance of studying lin-12/NOTCH regulators in multiple 
physiological contexts, where only using lin-12(n302) prevented us from making further 
conclusions about the kinase regulation of LIN-12/Notch. To that extent, it would be 





CKM negatively regulates LIN-12 independent of the Mediator core 
We continued our analysis of negative regulators of lin-12/Notch using the weak 
hypermorph, lin-12(n302). We removed individual Mediator core, CKM, and MED26 
components and looked for enhancement of lin-12 activity. We show in Chapter 4 that all 
four components of the Cdk8 Kinase Module are required for the negative regulation of 
lin-12/NOTCH. Loss or reduction of activity of a representative list of Head, Middle, and 
Tail components and mdt-26/MED26 failed to increase lin-12(n302) activity, indicating 
that CKM regulates lin-12 independent of the rest of the Mediator core.  
Additionally, kinase activity is not required for the CKM to bind to the Mediator 
core and subsequently block Pol II assembly to repress transcription (Knuesel, Meyer, 
Bernecky, et al., 2009). We prove that CDK-8 kinase activity is required for negative 
regulation of LIN-12/Notch, as an ectopically expressed kinase-dead form of CDK-8 is not 
able to rescue the Multivulva phenotype. This supports our conclusion that negative 
regulation of lin-12/NOTCH is not due to Mediator’s role in repression of transcription and 
is independent of the Mediator core. 
Cdk8 and Cyclin C are two components of the CKM, and have been shown to 
regulate different Notch target genes (Janody & Treisman, 2011) and embryonic stem cell 
pluripotency via different mechanisms (Adler et al., 2012) than the other two components 
of the CKM, MED12 and MED13. In our cellular context, we find that all four components 
of the CKM are required for negative regulation of LIN-12/Notch. Furthermore, in 
Drosophila, Kto/Med12 and Skd/Med13 physically associate with Su(H)/CSL (Janody & 
Treisman, 2011). Since the LIN-12 intracellular domain needs to be in the nuclear complex 
in order to be downregulated (as discovered in Chapter 2), it is possible that DPY-
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22/Med12 and LET-19/Med13 are recruiting the CKM to the nuclear complex via LAG-
1/CSL in order for CDK-8 to negatively regulate LIN-12. 
Despite all the structural and biochemical analyses of the Mediator core, much 
remains to be understood about the specific requirements for each component of the core. 
Our experiments systematically removed individual Mediator components and studied 
their effects on LIN-12/Notch. While we found that absence of any single component of 
the CKM drastically affects lin-12 activity, it may be possible that several components of 
the Mediator core have to be removed simultaneously to completely disrupt its regulation 
of lin-12. To that end, it will be useful to use RNAi and/or null allele combinations to 
remove several Mediator core components, and look for modification in lin-12 activity.  
 
CDK-8 kinase activity is required for downregulation of LIN-12/Notch   
cdk-8 is the kinase component of the CKM. It has been shown to phosphorylate 
several targets in different pathways (Nemet, Jelicic, Rubelj, & Sopta, 2014), including the 
Notch intracellular domain (N. Li et al., 2014). We found that LIN-12/Notch 
downregulation requires CDK-8 activity, which supports the current model stating that 
Cdk8 and Cyclin C regulate the Notch intracellular domain via phosphorylation of several 
sites in the CPD and the PEST domain (Fryer et al., 2004; N. Li et al., 2014). However, the 
implicated serines in human Notch are not conserved in the C. elegans LIN-12 intracellular 
domain, yet CDK-8 kinase activity is required for the downregulation of lin-12 activity. 
This suggests that, contrary to the current model, CDK-8 may be may be phosphorylating 
different sites in LIN-12, and not through recruiting SEL-10/Fbw7 at the CPD, at least in 
C. elegans. Alternatively, CDK-8 may be modulating lin-12 activity with SEL-10/Fbw7 
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via a divergent regulatory system in the C. elegans, and further experiments are needed to 
elucidate this mechanism.  
 
sur-2/MED23 and lin-25/MED24 uniquely promote lag-2 transcription 
Two Mediator Tail components, SUR-2/Med23 and LIN-25/Med24, had been 
previously found to facilitate Notch ligand production (Chen & Greenwald, 2004). We 
checked the rest of the Mediator core components and its modulators to see if they were 
involved in this process. We used arIs222[lag-2p::tagRFP] to assay for normal lin-12 
ligand transcription, and determined that sur-2/MED23 and lin-25/MED24 seem to 
regulate LAG-2 production independent from the rest of the rest of the Mediator Head and 
Tail subunits, CKM, and MED26. We did observe an absence of LAG-2 expression in 
mutants of the Middle components, mdt-4/MED4 and mdt-31/MED31, with the caveat that 
they also lacked LAG-2 expression in the gonad, which is not seen in sur-2/MED23 and 
lin-25/MED24 mutants. We speculate that mdt-4/MED4 and mdt-31/MED31 may be 
regulating gonad anchor cell specification and subsequent LAG-2 production in P6.p, and 
thus are not directly required for LAG-2 transcription per se. We can use the anchor cell 
reporter arIs51[cdh-3p::GFP] to confirm our theory and check for anchor cell 
specification in mdt-4 and mdt-31 mutants. We can also conduct tissue-specific rescue of 
mdt-4 and mdt-31 in the gonad to possibly restore anchor cell specification, then check for 
lag-2 transcription in P6.p. 
Taken together, we have systematically analyzed the Mediator core and modulator 
components for their functions in lin-12/NOTCH regulation and ligand transcription. We 
have isolated roles that the CKM plays in the negative regulation of lin-12 activity, and 
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that sur-2/MED23 and lin-25/MED24 plays in LAG-2 transcription. These findings 
contribute to the ever-growing list of pathways, where individual components of Mediator 
are important regulators independent of the rest of the multi-subunit complex. Furthermore, 
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